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Abstract 
The study of bone tissue development in vitro has received much attention over the years due to 
the increasing incidences of bone disorders worldwide. This has resulted in a growing need for 
improving the knowledge of bone cell physiology in order to investigate the causes and to develop 
potential treatments for bone diseases. One approach to this is by modelling osteoblast 
differentiation in vitro which usually involves culturing bone forming cells such as mesenchymal 
stem cells (MSCs) and bone derived cell lines such as MG-63 on two-dimensional (2D) culture 
plasticware. However, this culture environment results in alterations to the cell morphology, 
leading to changes in cell fate and differentiation potential as the microenvironment does not 
reflect the natural three-dimensional (3D) extracellular matrix in which cells reside in vivo. To 
overcome this, the development of 3D cell culture techniques has been widely investigated to 
better recapitulate the native environments of bone forming cells, thereby helping to enhance bone 
formation.  
 
This project describes the culture of bone forming cells on a 3D scaffold to investigate whether 
osteoblast differentiation and thereby bone formation will be enhanced when compared to 2D. 
Two types of bone forming cells were used in this study, primary rat MSCs and MG-63s. They were 
induced to undergo osteogenic differentiation via the use of osteogenic morphogens in both 2D 
and 3D culture conditions. Results indicated the increase in expression of osteoblast markers such 
as Collagen I and Alkaline Phosphatase in 3D cultures of MSCs and MG-63s. Additionally, matrix 
mineralisation was also suggested to be enhanced in 3D cultures. These results suggest bone 
formation is enhanced in 3D cell culture when compared to 2D methods and reveal the advantages 
of using a 3D cell culture system to model bone tissue development in vitro. However, more data 
and additional work is required to confirm these findings.  
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1. Introduction 
1.1 Bone anatomy and physiology 
Bone is a highly specialised and dynamic connective tissue that undergoes continuous remodelling 
in the body. Bone is responsible for many different functions in the body, with examples of the 
most significant roles being:  
• Support and protection of vital soft tissues  
• Locomotion  
• Providing rigidity and shape  
• Maintaining calcium and phosphate homeostasis  
In order to meet these responsibilities, bone tissue needs to be stiff in order to resist deformation 
yet flexible enough to absorb energy in response to mechanical stimuli1. There are a number of 
processes which allow for this, such as bone remodelling and mineralisation of its extracellular 
components which will be explored further. The human skeletal system is comprised of over 200 
individual bones, each with a different type (long, short, flat or irregular) and location in the body. 
Bones can be categorised into two distinct groups through their histology – cortical and trabecular.  
 
1.1.1 Cortical bone 
Cortical bone (also known as compact) is found at the dense external layer of long bones and the 
surfaces of flat bones2. It is solid and has a high matrix mass per unit volume, providing the cortical 
bone with substantial strength and rigidity to carry out its function of supporting muscle action and 
weight bearing1. Cortical bone is composed microscopically of osteons which forms the Haversian 
system. The Haversian system is arranged with blood vessels and nerves in the centre which are 
surrounded by concentric layers of calcified bone tissue, referred to as lamellae. This system allows 
the cortical bone to remain hard while being able to receive nutrients and dispose of waste through 
osteocytes in the channels3.  
 
1.1.2 Trabecular bone 
Trabecular bone (also known as cancellous) is the internal tissue which is found at the epiphysis 
(ends) of long bones and inner parts of flat bones. One of the key aspects of trabecular bone is the 
high porosity contained within the bone, with 50-90% of total trabecular bone volume being made 
up of pores4. The pores are interspersed within an internal highly ordered framework of trabeculae, 
which are interconnecting horizontal and vertical structural elements. Each trabecula is formed 
along lines of stress.  This gives the trabeculae strength and forms the characteristic spongy-like
 2 
 
 
Figure 1.1 Anatomy of a long bone and the microscopic structures involved in cortical bone. The structure of a long bone is shown with the gross anatomical 
characteristics labelled (A). The components which make up the basic structural unit of cortical (compact) bone (osteon) is shown in (B). Schematic adapted 
from OpenStax, Anatomy & Physiology. OpenStax CNX. Feb 26, 2016 http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@8.24.  
 3 
 
honeycomb appearance2. Although trabecular bone possesses less strength compared to cortical 
bone, one of its roles is to provide secondary mechanical support by offsetting the load and 
energy experienced by bone during movement. The high porosity of the bone allows trabecular 
bone to be lighter compared to the heavy, solid cortical bone. Other important functions of 
trabecular bone include maintaining mineral homeostasis and haematopoiesis1.  
 
1.1.3 Bone matrix  
The surface in which bone cells are embedded is referred to as the bone matrix. The bone matrix is 
composed of organic and inorganic elements, with the organic component being known as osteoid 
which is primarily comprised of collagen. Collagen is the major structural component of the osteoid, 
with type I collagen making up 90% of the organic matrix, along with other types of collagen (III, V, 
X, and XII)5. Collagen is a fibrous structural protein made up of individual collagen fibrils, which 
consists of 3 polypeptide chains (two 1 chains and one 2 chain) assembled into a triple helix 
procollagen molecule6. Osteoblasts are responsible for secreting the procollagen molecules, which 
converge together to form a collagen fibre. Collagen propeptides are cleaved off after secretion 
before the assembly to mature collagen fibres. This highly stable configuration is resistant to 
proteolytic degradation and provides the bone with flexibility. Intermolecular cross-links between 
collagens as well as the addition of inorganic minerals to the collagenous network gives the bone 
the stiffness and strength required for its mechanical properties7.  
 
The remaining 10% of the organic matrix is composed of noncollagenous proteins, with bone 
sialoprotein (BSP) and osteocalcin being the most abundant. BSP is a glycoprotein involved in 
mineralisation of the matrix by binding to calcium and hydroxyapatite, and has been suggested to 
be involved in osteoblast differentiation8. Osteocalcin makes up 20% of the noncollagen matrix 
proteins and is significant for matrix mineralisation and stabilisation of hydroxyapatite in the 
matrix9. However, its role in regulating osteoblast activity remain uncertain as it was found to 
decrease bone formation by osteoblasts10.   
 
The inorganic mineral components of the bone matrix is largely composed of hydroxyapatite, which 
are salt crystals formed when calcium phosphate and calcium carbonate combine. These crystals 
are found surrounding and within the collagen fibres, which is responsible for giving the bone the 
stiffness it requires. The inorganic matrix also acts as a reservoir store of 99% of the total body 
calcium, along with incorporating other inorganic salts such as phosphate, sodium and 
magnesium11,1.  
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1.1.4. Bone remodelling 
Bone is a metabolically active tissue which requires continuous remodelling in order to maintain 
the integrity of the skeleton and allow for adaptation to mechanical load and strain. This is achieved 
by 2 processes – bone formation and bone resorption.  
 
1.1.4.1 Bone formation and bone cell types 
Bone tissue is composed of the four cell types which make up the “Basic Multicellular Unit” of bone: 
osteoblasts, osteocytes, osteoclasts and bone lining cells. Bone formation occurs in two stages: 1) 
production of osteoid matrix, 2) mineralisation of the matrix.  
 
Osteoblasts are cuboidal cells which line along the surfaces of bone formation where they secrete 
the components of the osteoid and have a role in mineralisation. Active osteoblasts possess a 
prominent Golgi complex as well as numerous rough endoplasmic reticulum due to their main 
function of protein secretion7. Osteoblasts are polarised cells and only synthesise new organic 
matrix towards the bone surface during differentiation, which becomes mineralised. A layer of 
unmineralized matrix separates osteoblasts from the mineralised bone matrix, known as the 
osteoid seam. As the matrix becomes mineralised during bone formation, 10-20% of active 
osteoblasts become entrapped and either undergo apoptosis, differentiate into osteocytes12 or 
become bone lining cells7. Inactive osteoblasts (bone-lining cells) are flattened quiescent cells with 
little organelles and are found within bone surfaces which are not actively undergoing formation 
or resorption. These cells are important in forming a barrier between osteoclasts and bone matrix 
to prevent inappropriate bone resorption13.   
 
Osteocytes are the most abundant bone cell type, making up 90-95% of the total cells found in 
bone. Osteocytes carry out two major functions: regulate matrix mineralisation and to form 
connective cytoplasmic extensions (canaliculi). Osteocytes cells reside in a lacuna (empty space) 
within the mineralised matrix and form a network of long cytoplasmic extensions called canaliculi, 
which allows them to maintain contact with adjacent osteocytes and osteoblast on the surface1. 
This sensory network allows the osteocytes to sense local and systemic stimuli which impact the 
bone (e.g. hormonal/mechanical), causing the osteocytes to release signals to regulate osteoblast 
and osteoclast activity14.  Other roles of osteocytes which has been suggested include regulation of 
local mineral deposition15 and systemic phosphate levels in the kidneys16. Apoptosis of osteocytes 
which occur in response to local stressors such as microdamage, lack of mechanical stimulation and 
immobilisation produces a signal to neighbouring non-dying osteocytes to express RANKL, which in 
turns activates osteoclasts activity of bone resorption14,17.  
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1.1.4.2 Bone resorption 
Bone resorption is the process in which the mineralised matrix formed by osteoblasts during bone 
formation is removed by osteoclasts and is replaced by new bone formation.  There are three stages 
which is involved in bone remodelling: 1) Initiation of osteoclasts, 2) transition from resorption to 
new bone formation, 3) new bone formation by osteoblasts18.  
 
Osteoclasts are responsible for bone resorption - the process of the breakdown of bone. 
Osteoclasts can be activated to begin resorption from a range of trigger mechanisms such as 
mechanical forces, microdamage and systemic hormones1. This attracts cells of the haematopoietic 
lineage such as monocytes/macrophages to the site of resorption which become activated and fuse 
to differentiate into multinucleated osteoclasts. RANKL and macrophage colony-stimulating factor 
(M-CSF) are key proteins which are required for osteoclast maturation2. RANKL interacts with the 
RANK receptor located on the cell surface of pre-osteoclast precursors which triggers osteoclast 
formation, subsequently the precursors express fusion proteins such as DC-STAMP resulting in 
osteoclast progenitor fusion13,19. M-CSF is needed to stimulate osteoclast formation, as suggested 
by Yoshida et al who observed mice with non-functional M-CSF developing osteopetrosis due to 
lack of osteoclasts20. Mature osteoclasts attach to the bone surface via expression of αVβ3 integrins 
binding to matrix proteins containing the RGD amino acid sequence, such as osteopontin (OPN) and 
bone sialoprotein21. Osteoclast-bone interaction activates cytoskeletal reorganisation (podosomes) 
which are actively assembled and disassembled, resulting in osteoclast movement and resorption 
across the bone surface22.  
 
Resorption by osteoclasts involves acidification of the environment between the osteoclast and 
bone surface through the use of a proton pump. The acidic environment enhances the release of 
acid hydrolases in lysosomes which degrade the components in the organic matrix. Once resorption 
has completed, the osteoclasts undergo apoptosis and are removed from the resorption sites7,23,24. 
During bone remodelling, it is vital that bone resorption and bone formation is balanced in order 
to maintain bone homeostasis or risk the development of pathological conditions, such as 
osteoporosis. Figure 1.1.4 displays a summary of the processes involved in bone remodelling25.  
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1.2 Bone differentiation in vitro using different cell types 
Bone formation and osteoblast differentiation is widely studied in vitro using various cell types and 
models. Studies of bone is required in order to elucidate the mechanisms involved in processes 
such as bone remodelling as there are still uncertainties over the cytokines and hormones which 
regulate bone activity13. Knowledge of the underlying normal physiological mechanisms involved in 
bone formation and repair will help to develop preventions and treatments for bone disease.  
 
Another important aspect of studying bone differentiation and formation in vitro is for the 
development of regenerating and repairing of bone tissue which is lost due to fractures, tumours 
and injuries etc26. Bone tissue engineering is a highly promising area of science research which has 
been made possible due to the bone being a tissue which has high potential for regeneration, such 
as during fracture healing. In vitro studies of bone remodelling will help to progress the 
developments made in the field of bone tissue engineering even further.  
 
 
Figure 1.1.4 The processes involved in bone remodelling. Bone remodelling is a finely balanced 
process which occurs in order to maintain the strength and integrity of bone. Bone resorption 
involves haematopoietic stem cells (HSC) differentiating into osteoclasts which is responsible for 
demineralising the bone matrix. Osteoblasts which are derived from MSCs (mesenchymal stem 
cells) are bone making cells involved in bone formation, which in turn differentiate into 
osteocytes – cells responsible for maintaining bone. Adapted from Weilbaecher et al, 201125.  
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1.2.1 Mesenchymal stem cells  
Mesenchymal stem cells (MSCs) are widely used to study bone tissue formation in vitro and hold 
great promise for use in bone tissue engineering. MSCs are readily expanded in vitro, and their 
ability to self-renew and differentiate into multiple lineages results in huge therapeutic potential.  
 
1.2.1.1 History and discovery of mesenchymal stem cells   
Stem cells are defined as unspecialised cells which possess the ability to self-renew indefinitely and 
are able to differentiate into multiple specialised cell lineages when stimulated with physiological 
or experimental conditions27. MSCs are multipotent stromal progenitor cells capable of 
differentiating into cells of three mesodermal lineages – osteogenic, adipogenic and chondrogenic. 
The discovery of MSCs in vitro is credited to Friedenstein et al who observed that cells derived from 
bone marrow stroma were able to generate cells of bone, adipose and cartilage origin after a series 
of heterotopic transplantations. They showed that these cells were distinct from haematopoietic 
stem cells which also reside in the bone marrow28. These multipotent precursor cells had similar 
structures to fibroblasts, hence initially being called colony-forming unit fibroblasts (CFU-FU) and 
could be selected via plastic adherence29. However, further studies confirmed their ability to 
proliferate while differentiating into mesenchymal lineages in vitro, therefore suggesting they were 
actually stem cells and the name “mesenchymal stem cells” was coined 30. 
 
1.2.1.2 Challenges of the characterisation of in vitro MSCs 
Since the discovery of MSCs in the bone marrow, there have reports of MSCs/MSC-like populations 
being found in other adult tissues. These include adipose tissue, peripheral blood, heart and 
kidney31,32,33,34. However, the most well characterised source of MSCs remains the bone marrow.  
The characterisation of MSCs in vitro has remained challenging, mainly due to different laboratories 
using various isolation and in vitro culture methods. This has led to inconsistency in reports of the 
in vitro properties of MSCs which has provided setbacks to MSC research35and also makes cross-
study comparisons difficult. In order to standardise studies, the International Society for Cellular 
Therapy provided guidelines for MSC characterisation. This includes three minimal criteria which 
cells need to possess in order to be defined as “multipotent mesenchymal stromal cells”, however 
the name “mesenchymal stem cells” is still most widely used36. 
These are: 
• Plastic-adherent in culture conditions 
• Positive for a combination of surface antigens (CD73, CD105, CD90) and negative for 
haematopoietic markers (CD34,  CD45, CD11a, CD19, CD14, HLA-DR) 
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• Can differentiate into osteoblasts, chondrocytes and adipocytes under the appropriate 
conditions 
 
1.2.1.3 Bone marrow niche and stimulants of MSC osteoblast differentiation in vitro 
Like all stem cells, MSCs reside in niches which are local tissue microenvironments which contain 
the suitable conditions to maintain and regulate stem cells. The bone marrow niche is comprised 
of a heterogenous population of cells, including haematopoietic stem cells (HSCs), fibroblasts and 
progenitor cells. MSCs have been consistently reported to lie adjacent to blood vessels, and are 
thought to contribute to the homeostasis of haematopoietic cells in the bone marrow37,38.  
 
In the body, MSCs readily differentiate into osteoblasts during bone formation. This multistep 
process can be modelled in vitro through the addition of bone morphogens to the culture media 
which have been shown to induce osteogenic differentiation by MSCs. The most common cocktail 
of osteogenic stimulants added to MSC cultures to induce osteogenic differentiation is: 
dexamethasone, ascorbic acid and -glycerophosphate39.  
 
Dexamethasone is a common stimulant which is added to cultures to induce osteogenic 
differentiation. Dexamethasone is a glucocorticoid steroid which has been shown to stimulate 
osteogenic differentiation of bone marrow-derived stromal cells by augmenting proliferation and 
selecting for cells with higher osteogenic capability in vitro40. It is believed that the dexamethasone 
upregulates the expression of Runx2, a key transcription factor which is required for osteoblast 
differentiation41. One mechanism which has been identified to elucidate this is through 
dexamethasone increasing Runx2 co-activator TAZ in rat bone marrow MSCs, which suppresses 
adipogenic differentiation while promoting osteogenic differentiation41,42. 
 
Likewise, the addition of ascorbic acid further enhances osteogenic differentiation through 
promoting MSC proliferation and extracellular matrix synthesis of collagen I fibres43. The role of 
ascorbic acid in osteogenic differentiation is to act as a cofactor for the enzymes which carry out 
hydroxylation of proline and lysine residues in pro-collagen, allowing the formation of the helical 
structure of collagen41. Without ascorbic acid in the culture media, cells are unable to synthesise 
and secrete collagen in the extracellular matrix44 – collagen is a vital component of the bone 
extracellular matrix, therefore showing the importance of ascorbic acid in stimulating osteogenic 
differentiation.   
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Furthermore, the supplementation of -glycerophosphate in culture media facilitates osteogenic 
differentiation through hydrolysis by the alkaline phosphatase enzyme (ALP)45. This provides a 
source of inorganic phosphate which is crucial for the production of hydroxyapatite mineral during 
mineralisation of the bone matrix. A study which cultured rat osteoblast-like cells reported a 
decrease in in vitro mineralisation and loss of calcium phosphate deposition during inhibition of -
glycerophosphate, reducing bone formation46. Another important function of inorganic phosphate 
is to activate the ERK signalling pathway which regulates significant osteogenic genes, such as 
osteopontin (shown in murine cementoblasts)47.  
 
Other stimulants of osteogenic differentiation which have been added to MSC culture media 
includes several members of bone morphogenetic proteins (BMPs). BMP2 and BMP4 added to 
cultures of primary bone marrow murine cells and were found to be essential for both osteoblast 
and osteoclast commitment and formation48. The addition of growth factors such as transforming 
growth factor beta (TGF-) have been shown to stimulate collagen synthesis in cells from fetal rat 
bone49. Notably, the inclusion of TGF- in cultures of bone marrow stem cells resulted in senescence 
of cells and production of mitochondrial reactive oxygen species (mtROS)50. The role of TGF- in 
osteogenic differentiation needs to be explored further for clarification of its effects on osteoblast 
differentiation45.  
 
 
 
 
 
 
Figure 1.2.1.3 The proposed signalling pathways involved in dexamethasone and scorbic acid 
inducing osteogenic differentiation of stem cells. For dexamethasone (Dex), there are various 
transcription factors which dexamethasone can increase the expression of. This includes FHL-2 and 
Runx2 which are involved in the regulation of osteogenic differentiation. The addition of ascorbic 
acid (Asc) increases collagen synthesis which in turns increases the signalling pathway which leads to 
activation of Runx2. Abbreviations: ECM, extracellular matrix; +OH, hydroxylation; MEK, MAPK/ERK 
Kinase; FAK, Focal Adhesion Kinase; P, phosphate. Adapted from Langenbach et al, 2013.  
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1.2.1.4 The stages and markers of osteogenic differentiation of MSCs in vitro  
The process of MSCs undergoing osteogenic differentiation to form osteoblasts can be 
recapitulated in vitro through a 3 week culture using osteogenic medium containing 
dexamethasone, ascorbic acid and -glycerophosphate51. The result of bone formation by MSCs in 
vitro are the presence of mesenchymal condensations which form bone-like nodules52. During this 
time, three key stages occur which result in differentiated osteoblasts – 1) Proliferation, 2) 
Extracellular matrix development and maturation and 3) Matrix mineralisation53.  
 
Proliferation is the first stage of osteogenic differentiation of MSCs, whereby cell proliferation 
genes are upregulated and cells undergo replication to increase cell number. High expression of cell 
cycle genes such as histones and proto-oncogenes (c-fos and c-myc) can be seen during the first 10-
12 days of culture, reflecting the highly proliferative nature of cells53,54. Although overexpression of 
c-Myc in cultures of human MSCs in vitro promoted proliferation, osteogenic differentiation was 
ultimately reduced. This suggests that proliferation needs to be higher at earlier stages but needs 
to be reduced in order to achieve maximum osteogenic differentiation rates. In control cultures, c-
Myc levels naturally declined after day 14 in order to proceed to the next stage (matrix maturation), 
showing the importance of a reduction in proliferation after the early stage of osteogenic 
differentiation55.  
 
Following proliferation, MSCs continue their differentiation into mature osteoblasts through 
developing the extracellular matrix by the upregulation of key osteoblast proteins. ECM formation 
begins to accumulate between one to two weeks of culture. This stage is characterised by the 
production of extracellular deposits, mainly containing calcium and inorganic phosphates52. ALP is 
an metalloenzyme secreted by osteoblasts which is membrane bound and has a phasic expression 
during differentiation. ALP expression is increased during early osteoblast commitment and 
extracellular matrix formation but is downregulated during mineralisation and later stages53. ALP 
expression reaching a peak at day 14 of culturing osteogenic-induced MSCs in vitro has been widely 
reported across literature56–58. ALP expression is commonly used as an marker of osteoblast 
differentiation by MSCs. Other important growth factors and proteins secreted by osteogenic-
induced MSCs for ECM formation and maturation include fibronectin, vitronectin, collagen and  
osteopointin (OPN) which are all used as markers of osteoblast differentiation in vitro59. Fibronectin 
is a glycoprotein found in the ECM which has been suggested to have a role in osteogenesis, with 
the expression of fibronectin mRNA being increased during early stages of osteoblast maturation60. 
Fibronectin is believed to be important during the initial attachment of osteoblasts to the matrix, 
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as it has been shown to be deposited in areas of osteoblast recruitment61. Integrins such as BMP-4 
have been found to enhance fibronectin assembly into the extracellular matrix by rat osteoblasts62.   
 
The hallmark of final stage of osteogenesis by MSCs after induction by bone morphogens is 
mineralisation of the ECM, which involves the generation of calcium phosphate63. The main 
technique used to assess the levels of matrix mineralisation in vitro are histological stains, such as 
Von Kossa and Alizarin Red. The Von Kossa stain involves the use of silver nitrate solution whereby 
the silver cations replace calcium cations that have been bound to anionic phosphates. This can 
then be visualised as the silver salts are reduced to metallic silver under light, which are seen as 
dark brown or black deposits64,65. In contrast, Alizarin Red reacts directly with calcium cations by 
forming chelates which is orange to red in colour66. Both histological stains are widely used to 
visualise calcium deposits, which is an indicator of mineralisation of the extracellular matrix by 
osteogenic-induced MSCs.  
 
The expression of several genes is also involved during the mineralisation stage of osteoblast 
differentiation. Osteonectin (ON) (also known as SPARC) is a bone-related protein which reaches a 
peak during the initiation of mineralisation (16-20 days)52 which is important for the binding of 
calcium, hydroxyapatite and fibrillar collagen67. Osteocalcin (OCN) is considered as a marker of 
mature osteoblasts as its expression only occurs after ALP activity and mineral deposition which 
occurs during the later stages of osteoblast differentiation68. The role of OCN in osteoblast 
differentiation is thought to be involved with regulating bone mineralisation and turnover69.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.1.4 Illustration of the three stages involved in osteogenic differentiation of MSCs in vitro.  The 
stages are: 1) Proliferation, 2) ECM remodelling (maturation) and 3) ECM mineralisation. The 
morphological changes and gene expression involved at each stage is shown above the respective step. 
Two restrictive points are associated with the osteogenic differentiation. The first point is the 
downregulation of proliferation in order to increase ECM accumulation while the second refers to the 
downregulation in ECM remodelling for mineral mineralisation. Abbreviations: ALP, alkaline phosphatase; 
BMPs, bone morphogenetic proteins; BSPII, bone sialoprotein; COL-I, collagen I; ECM, extracellular matrix; 
NDP, nucleoside diphosphate; OB, osteoblast, ON, osteopointin; PTHrP/PTHIR, parathyroid hormone 
related-protein. Adapted from Alami et al, 2016.  
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1.2.2 Primary cells and cell lines 
Other cell types have also been used to model bone tissue formation in vitro outside of MSCs. 
Although primary human MSCs would be the most favourable cell culture model to use as it would 
be more relevant for clinical studies, there are some disadvantages with using primary human MSCs 
e.g. limited accessibility and a difficult isolation procedure. The tissue site of human MSC isolation 
can also exhibit functional differences e.g. MSCs isolated from orofacial bone marrow proliferate 
faster and have a higher ALP activity compared to iliac crest bone marrow MSCs collected from the 
same individuals70. Similarly, primary mouse/rat MSCs are also widely used and are much more 
easily available compared to human. However, there are interspecies differences and genomic 
differences which could make studies less comparable to humans studies71.  
 
Primary osteoblasts cells have also been investigated for use in in vitro bone tissue models as the 
terminally differentiated cells can be isolated from bone tissue, and are able to be expanded in 
culture. Osteoblasts can be isolated from rodents such as mouse and rat and have been widely used 
in studies. Rat osteoblast cells can be isolated from foetal, neonatal/adult calvaria or long bones 
and have been shown to retain their osteoblastic characteristics in culture, making it a suitable 
model for in vitro bone formation72. Similarly, osteoblasts have been isolated from mice, through 
their calvaria and long bones and were reported to deposit a collagenous ECM and form mineralised 
bone nodules73. However, the osteoblastic phenotype of both rat and murine osteoblasts are 
influenced by donor age. A comparative study reported osteoblasts isolated from 7 day old rat tibia 
needed 41 days to form mineralised nodules compared to only 21 days for foetal cells74. Likewise, 
expression of ALP activity was greater from mouse adult long bone compared to adult and neonatal 
calvarial cells75.  This could produce results which are hard to compare between studies and may 
not be clinically relevant to human trials, as well as the issue of interspecies differences. 
 
Additionally, cells from immortalised cell lines have been used to model osteoblast behaviour in 
vitro. There are many advantages to using cell lines instead of primary cells, including the ease of 
maintaining cultures and the supply of unlimited number of cells. There is also no need for the 
process of isolating cells which reduces the time needed to set up cultures. Various human cell lines 
have been isolated and characterised, including SaOs-2 and MG-63.  
 
SaOs-2 is a human osteosarcoma cell line which was first isolated from an 11-year old female in 
197576. Cells from SaOs-2 possess a mature osteoblast phenotype and have been shown to express 
much higher ALP activity compared to human primary osteoblasts after 14 days of culture77. SaOS2 
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cells have been able to produce bone-like mineralised matrix and have been used to investigate 
osteoblast differentiation into osteocyte-like cells78.   
 
MG-63 is another cell line derived from human osteosarcoma, originally isolated from the left femur 
of a 14 year old male79. This study also reported the use of MG-63 in the production of human 
interferon, which have clinical applications in cancer therapy and have been investigated in the 
treatment of multiple sclerosis80. The cells exhibit rapid cell growth81, which is useful in large scale 
studies which require an unlimited source of cells. MG-63 cells exhibit similar behaviour to normal 
primary human osteoblast cells in response to hormones such as 1,25(OH)2 (active form of Vitamin 
D)82 and parathyroid hormone treatment83, suggesting MG-63 cells would be useful in 
recapitulating the hormonal regulation of the osteoblastic phenotype during bone formation and 
resorption.  
 
However, a study which characterised the extracellular matrix production of SaOs-2 and MG-63 
cells reported differences in production in vitro compared to normal primary human osteoblasts. 
MMP-9 and collagen-X were found in the osteosarcoma cell lines but were not detected in normal 
osteoblasts. The levels of osteoblast maturity differed between SaOs-2 and MG-63, with SaOs-2 
exhibiting the most mature phenotype by displaying positive results for markers such as ALP, 
osteocalcin and collagen I/III but only in a small population of cells (15%). No ALP activity could be 
detected in MG-6384. The increasing phenotypic heterogeneity with prolonged passaging of cells 
has been reported84–86 which may limit the use of osteosarcoma cell lines in resembling the 
behaviour of primary osteoblast cells. Despite this, they are still commonly used in studies due to 
their ease of culture compared to primary cells and are a beneficial source of cells for pilot model 
studies of osteoblast functionality87.   
 
1.3 Modelling bone development in vitro – 2D vs 3D 
Since the first isolation and in vitro culture of osteoblast cells from human bone was investigated 
in 1972 by Bard et al88 , much efforts in improving the knowledge of bone cell physiology has been 
derived from experiments cultured using polystyrene substrates. Traditionally, cell culture models 
have been maintained using techniques which involve growing cells on polystyrene or glass flat 
two-dimensional (2D) surfaces, creating the traditional monolayer of cells. There are many 
advantages to using this gold standard in vitro cell culture method. This includes:  
• Ease of use  
• Low costs  
• High levels of standardisation  
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• Allowing for great control over culture environments 
 
However in 2D, cells are cultured on flat and rigid substrates which do not reflect the three-
dimensional (3D) extracellular matrix all cells reside in vivo. This results in various cell changes such 
as in gene expression, morphology and polarity, thus providing results which are inconsistent with 
and nonpredictive for how cells behave in vivo. In 2D, cells have been shown to detect the in vitro 
environment which results in forced-polarity due to contact with substrates on one side of the cell 
and cell flattening and ultimately gene expression changes which do not reflect the cells’ usual 
behaviour in vivo89.  To mitigate these limitations, 3D cell culture aims to bridge the gap between 
the in vivo and in vitro cell environments through better recapitulating native microenvironments. 
This is through incorporating mechanical signals, improving cell-cell and cell-matrix interactions as 
well as creating spatial gradients of soluble factors in the cell environment90. There have been 
various techniques of 3D cell culture developed, all with the aim of better mimicking the in vivo 
environment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1.3. Schematic displaying the effect of the 2D and 3D environments on cell morphology. 
The in vivo 3D structure of cells is not reflected in the in vitro 2D environments as the cells detect 
the environment and adapt a flattened morphology as a result. Adapted from ReproCELL Europe 
Ltd.   
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1.3.1 2D models of in vitro osteoblast differentiation  
The process of osteoblast differentiation has been extensively investigated in vitro using 2D 
conditions. The complete stages of osteoblast differentiation (from proliferation to mineralisation) 
can be recapitulated in the monolayers of bone forming cells. Lian and Stein first reported the 
sequence of expression of osteoblast markers during each stage of osteoblast differentiation using 
a monolayer of cells derived from rat calvaria91, which is now widely used in studies to monitor the 
development of bone forming cells in culture. Since then, many different cell types have been 
grown using 2D cell culture which have been shown to undergo the full osteoblast differentiation 
process (as discussed in Section 1.2). Nonetheless, in some studies involving the culture of adult 
human derived osteoblasts, cells cultured under 2D conditions produced unsatisfactory levels of 
late stage osteogenesis92,93. Additionally, MSCs propagation using 2D cell culture alters their cell 
morphology, leading to changes in cell fate and differentiation potential94. In particular to bone 
tissue, bone cells communicate and interact with each other through the ECM via soluble factors 
or cell-cell/cell-matrix interactions. Evidently, 2D monolayer culture conditions are not able to 
recapitulate these conditions in vitro and is not physiologically relevant, illustrating the need for 3D 
cell culture systems to create an environment which is more like the in vivo niches in which bone 
cells live.  
 
1.3.2 3D models of in vitro osteoblast differentiation - Spheroids 
The use of 3D cell culture technologies used to cultivate bone forming cells and model osteoblast 
differentiation has become increasingly popular. There are many different types of 3D cell 
technologies, one of the simplest methods is spheroid formation. Maintaining bone forming cells 
in spheroids involves cells being prevented from adhering to the plastic and instead are stimulated 
to form multicellular aggregates. There are multiple methodologies for aggregate formation, 
including the spinner flask method, whereby the cell suspension undergoes continuous agitation to 
inhibit cellular attachment to the solid surface. Another technique involves using agar to prevent 
cellular attachment to the culture-plate bottom95. One of the most common techniques of 
generating spheroids is through the hanging drop method whereby the cell suspension is placed in 
a drop on an inverted tissue culture dish lid, allowing gravity to aid cells to aggregate together at 
the bottom of the drop96. Spheroid formation allows for greater cell-cell and cell-matrix interactions 
which more closely mimics their cellular niche as the cells are supported by the ECM produced by 
the cultured cells. Cultivating mouse bone marrow stromal cells in hanging drops resulted in long 
term survival and stemness, as well as differentiation into multiple lineages including osteogenic97. 
Additionally, culturing human bone precursor and osteoblast cells which are induced with TGF1 
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resulted in the upregulation of bone markers such as alkaline phosphatase, collagen I and 
osteonectin compared to monolayer cells in 2D98.   
 
Despite this, there are some limitations of culturing cells in spheroid formation. Due to the structure 
of the spheroid, the diffusion of nutrients, oxygen and waste through the centre of the spheroids 
are limited in larger spheroids – with increasing size of spheroids, the greater the decrease in 
oxygen concentration and cell viability99,100. This results in the internal core of spheroids being 
hypoxic. Spheroid culture of MSCs have reported an upregulation of hypoxia-associated genes such 
as VEGFA101 and a stress response is induced102. The effect of oxidative stress and the production 
of reactive oxygen species (ROS) on MSCs has been shown to inhibit proliferation and reduce 
osteogenic differentiation103. Similarly, oxidative stress (as modelled by the addition of exogenous 
H2O2) suppresses osteogenic differentiation by osteoblastic cells through antagonising Wnt 
signalling104 – a vital stimulus for the induction of osteogenesis.  
 
1.3.3 3D models of in vitro osteoblast differentiation – Scaffolds 
As previously mentioned, the use of spheroids is not suitable for larger 3D models due to the 
problem of nutrient exchange in the internal structure. To counter this, the use of scaffolds to 
support 3D growth of cells is common for modelling in vitro osteoblast differentiation and for bone 
tissue engineering. Scaffolds provide a surface for cells to attach and provide a microenvironment 
which aims to mimic the features found naturally within their native extracellular matrix in vivo. 
When designing scaffolds for 3D cell culture, the properties of the cells which are being cultured 
must be taken into account. The requirements for 3D scaffolds for culturing bone cells should 
reflect the natural bone matrix – highly porous with interconnected pores which are able to support 
cell attachment, proliferation and ECM formation105. For osteoblasts, a hard surface scaffold is 
appropriate to recapitulate the solid surface of bone in which osteoblasts attach to. Scaffolds can 
be fabricated from a variety of materials – either natural or synthetic106.  
 
Scaffolds derived from natural materials are typically components of the ECM such as collagen, 
elastin and fibrin. Type I Collagen scaffolds are one of the most commonly used natural scaffolds 
for modelling osteogenesis by bone forming cells in vitro. 90% of the organic matrix in bone is 
composed of Type I Collagen107, therefore it is fundamental to bone formation and suggests it could 
be useful for 3D cell culture of osteogenic cells. Culturing primary human bone marrow-derived 
MSCs on a collagen scaffold with immobilised ALP resulted in the enhancement of osteoblast 
differentiation due to upregulation of several key osteoblastic genes such as ALP, Collagen I and 
osteocalcin and downregulation of osteogenic differentiation inhibitor tumour necrosis factor-108. 
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Similarly, the cultivation of osteoblastic cell line MC3T3-E1 displayed earlier mineralisation when 
cultured on a 3D collagen gel compared to 2D. The same study also reported the increased 
expression of osteoblast genes from primary rat osteoblasts when cultured on the 3D collagen gel 
compared to 2D109.  
 
Likewise, the use of natural material and synthetic scaffolds have also been shown to promote 
osteogenic differentiation. A study by Datta et al seeded primary rat MSCs onto scaffolds composed 
of titanium fibre meshes, in which the MSCs secreted ECM onto the scaffold. The scaffold was then 
decellularized and re-seeded with fresh MSCs without the osteogenic supplements and only 
induced to differentiate using the ECM previously deposited on the scaffold. The results of the study 
illustrated increased expression of osteopontin and calcium deposition compared to cells which 
were only seeded once on day 16, indicating the bone-like ECM synthesised in vitro on scaffolds 
can be used to enhance MSC osteoblast differentiation110. This demonstrates the versatility of 
scaffolds and how 3D cell culture can be used to enhance osteogenesis in vitro.  
 
  
Figure 1.3.3 Overview of 2D and 3D cell culture techniques for osteogenic (OS) cultures. 2D 
osteogenic cultures involve cultivating cells using plastic tissue flasks which form monolayers. 3D cell 
cultures can be categorised according to scaffold or scaffold free. An overview of the processes 
involved and materials used is given. Adapted from De Luca et al, 2018106.  
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1.3.4 Scaffolds for bone tissue engineering  
Not only can 3D cell culture support an in vitro osteoblastic model, bone cells cultured on scaffolds 
can be used for bone tissue engineering (BTE). The fundamental aim of tissue engineering involves 
being able to replace diseased or damaged tissue with a structure grown on a scaffold regenerated 
in vitro or induced in vivo111. BTE involves the use of biomaterials and cells to induce new functional 
bone regeneration either for bone defect repair or for bone grafts. Bone is naturally self-repairing 
therefore one of the aims of BTE is to promote this process with the induction of materials 
generated in vitro. BTE is a rapidly expanding field due to the increasing worldwide incidence of 
bone disorders which require bone graft treatment. There are many components which are 
important to the field of bone tissue engineering112:  
• Biocompatible scaffold which recapitulates the in vivo bone matrix 
• Signals that direct osteogenic differentiation of osteogenic cells  
• Osteogenic cells to produce the matrix  
• Vascularisation in order to supply the nutrients and waste disposal of the tissue   
 
One fundamental aspect of BTE is that if a scaffold is used for implantation for clinical purposes, 
the scaffold should be biodegradable in order for the implantation to be remodelled by the body 
and is then replaced by native tissue, thereby restoring original function. The scaffold must not 
produce any toxic or immunogenic responses during the breakdown in the body111.  
 
Similar to scaffolds designed for in vitro modelling, scaffolds for BTE can be fabricated from a range 
of natural and synthetic materials. The choice of material for scaffolds should be biocompatible and 
the body must be able to metabolise the monomeric products without producing an inflammatory 
response. Commonly used materials for BTE include synthetic polymers such as poly glycolic acid 
(PGA) and poly lactic acid (PLA) which have been investigated for their excellent mechanical 
properties. PGA is advantageous for BTE as its fibres exhibit high tensile strength at 7.0 GPa, 
allowing for a strong and biodegradable material to support BTE113. PLA exists in enantiomeric 
states due to its chirality and these states have comparable tensile strength (4-8 GPa) and a slow 
crystallising nature which results in a hard and brittle material, useful for fixation-devices such as 
screws for orthopaedic applications114.  These polymers also possess characteristics such as 
biocompatibility, being biodegradable and can be assembled into different shapes115. Degradation 
over time helps with the integration of cells with host tissue during transplantation. The 
degradation rates of scaffolds manufactured from PGA/PLA can be controlled as higher PGA 
content degrades faster111.  Seeding rat osteoblasts onto PGA and PLA substrates resulted in 
significant attachment, increase in ALP activity and enhanced collagen synthesis compared to cells 
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grown on normal tissue culture polystyrene116. This demonstrates the suitability of PGA/PLA as 
temporary substrates to transplant osteoblasts in vivo for use in bone regeneration.   
 
Natural polymeric scaffolds composed of components of the ECM have been used in BTE due to 
their osteoinductive properties. There are three classes of natural biomaterials which are proteins 
(silk, collagen, gelatin etc), polysaccharides (cellulose, dextran, chitin etc) and polynucleotides 
(DNA,RNA) which have all been used as they naturally enhance the cells function in a biological 
system117. However, natural polymers are either cell-derived or tissue-derived which causes issues 
with immune rejection if they are not from the same person (allogenous or xenogenous constructs) 
as well as risk of disease transmission. Autogenous scaffolds require additional surgery and is not 
as widely available as allogenous scaffolds115. The main concern of using natural polymers as 
scaffolds for BTE is the lack of mechanical support for bone scaffolds as they provide insufficient 
architectural support for osteogenic cells118. To minimise this limitation, natural polymeric scaffolds 
are usually combined with other materials to produce composite scaffolds which possess excellent 
mechanical properties such as increasing tensile strength with the addition of polycaprolactone 
PCL119 and high osteoconductivity as discussed below.  
 
Bioceramics such as hydroxyapatite and calcium phosphate are naturally occurring in the bone 
matrix and have been used for their osteoinduction properties. Composite scaffolds containing 
bioceramics, synthetic polymers and natural polymers have been commonly used during bone 
repair studies and for BTE purposes120,121. An example of this is a study by Phipps et al who 
investigated the use of a nanofibrous bone-mimicking tri-component scaffold comprised of 
polycaprolactone (PCL), collagen I and hydroxyapatite for culturing MSCs. Compared to culturing 
MSCs on each component alone, MSCs on the tri-component scaffold displayed faster cell 
spreading, attachment and greater cell proliferation. An increase in the osteoblastic signalling 
molecule FAK was also reported. This suggests the combination of materials in the scaffold holds 
great promise for the delivery of exogenously expanded osteogenic cells as well as potentially 
inducing bone repair in vivo119.  
 
Although there are many polymeric materials which have the potential to be suitable for BTE, no 
single polymer possesses all the requirements necessary for successful in vivo bone tissue 
regeneration. Due to this, composite scaffolds can provide a balance between the advantages and 
disadvantages of each individual component and deliver an overall better suited scaffold for BTE. 
Moreover, as discussed previously, bone matrix in vivo is naturally a mix of organic and inorganic 
components. This suggests composite scaffolds could become the optimal scaffolds for BTE122. 
 20 
 
1.4 Example of 3D cell culture technology – Alvetex  
 Alvetex (ReproCELL) is a rigid, inert scaffold designed for routine in vitro 3D cell culture. It is 
comprised of a highly porous polystyrene membrane engineered by high internal emulsion 
templating (polyHIPE)123. The scaffold is available as well inserts, designed to fit into conventional 
2D cell culture plasticware. Polystyrene has been the fundamental platform used for adherent 
animal and human cell culture due to its long shelf life, ease of manufacture and low production 
cost124 allowing for mass production of Alvetex. Polystyrene is also a material which is used in 2D 
culture plasticware, therefore showing its suitability for cell culture and allows comparisons to be 
made between 2D and 3D. The highly porous nature of Alvetex is made up of a homogenous 
network of voids, linked by interconnecting pores which allows cellular attachment and interactions 
with neighbouring cells. The membrane of Alvetex is engineered to be 200m thick, which is thin 
enough to allows cells to gain access to nutrients and  exchange gases and waste products during 
static culture125. Crosslinks in Alvetex provide structural strength and stability to the thin 
membrane. The scaffold has been previously applied to a range of in vitro models, including co-
cultures of dermal fibroblast and keratinocytes in a full thickness skin model126, neurite outgrowth 
model127 and a human airway mucosa model128.  
1.4.1 Alvetex as a scaffold for an in vitro bone tissue model 
Alvetex scaffold is considered to be a suitable material for cultivating bone forming cells in an in 
vitro bone tissue model for a number of reasons. Firstly, one of the requirements for a 3D system 
for culturing bone cells is the resemblance to the bone matrix105. Bone matrix is naturally highly 
porous with interconnected pores which supports the attachment and proliferation of bone 
forming cells. Since the membrane of Alvetex is highly porous and the structure is comparable to 
the in vivo bone matrix, it fulfils this requirement. It has been suggested that scaffolds with a highly 
interconnected architecture have significant impact on MSC signalling and differentiation and 
ultimately affects bone formation129. The high porosity of Alvetex also suggests it would allow 
greater cell-matrix interactions which is vital during osteogenesis. Although the pore sizes differ 
greatly between Alvetex scaffold (38m) and trabecular bone (300 - 600m)130,131, the internal 
organisation of the pores are comparable (Figure 1.4.1). Another property of Alvetex which makes 
it an attractive tool for modelling bone tissue in vitro is the requirement of a solid material for bone 
cells to attach. Alvetex is fabricated from polystyrene material which have been shown to be able 
to support osteogenic differentiation in 2D cultures73, therefore suggesting it is an appropriate 
material for cultivating bone forming cells. Previous work at Durham University involved culturing 
MSCs132 and MG-63s133 on Alvetex, however the results were only preliminary and the 
osteogenesis by these bone forming cells on the scaffold requires further extensive 
characterisation.  
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1.5 Project aims and objectives  
This project aims to develop an in vitro bone tissue model using primary rat MSCs and cells from 
the human osteosarcoma cell line MG-63. The models will be compared between using 2D tissue 
culture plasticware and 3D scaffolds to investigate whether bone formation will be enhanced using 
3D cell culture. This would allow for an in vitro model which could be used to further develop our 
understanding of the mechanisms behind bone formation and remodelling.  
 
Project objectives:  
• To isolate and characterise primary rat MSCs  
• To identify and culture a bone derived cell line such as MG-63 
• To induce bone formation in vitro 
• To investigate whether 3D scaffolds will support the growth of bone forming cells  
• To analyse the formation and deposition of extracellular matrix by bone forming cells 
• To determine whether bone nodule formation is enhanced in 3D cell culture 
 
1.5.1 Project hypothesis  
The hypothesis for this project is that culturing bone forming cells on a 3D scaffold which more 
closely resembles the structure of bone will provide a microenvironment more similar to the in vivo 
bone marrow niche. This will result in the enhancement and increase of the expression of 
differentiated bone markers in 3D by MSCs and MG63s, compared to growth on a 2D environment.  
Figure 1.4.1 Comparison of the porous internal structure of Alvetex and trabecular bone. 
Scanning electron microscopy images of Alvetex
 
scaffold (A) and human trabecular bone (B) at 
800x magnification and 23x magnification respectively. Similar organisation of the porous 
networks can be seen between Alvetex
 
scaffold and human trabecular bone. Images provided 
by ReproCELL Europe Ltd (A) and adapted from Kytyr et al, 2012 (B).   
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2. Materials and Methods 
2.1 Mesenchymal Stem Cells  
2.1.1 Isolation of rat bone marrow MSCs  
Rat mesenchymal stem cells (MSCs) were isolated from the femurs and tibiae of adult Wistar rats 
using established protocols 134. Rats were euthanised by cervical dislocation method. The femurs 
and tibiae were extracted from the back limbs and cleaned of connective tissue and muscle. These 
were placed in a beaker containing 70 % ethanol for a few seconds before being transferred to a 
beaker of 1 x DPBS (Dulbecco’s Phosphate-Buffered Saline). They were kept in PBS and transferred 
into a sterile class II cell culture hood.  
 
In a cell culture hood, the femurs and tibias were placed in a glass petri dish and the ends of the 
bones were cut open with scissors. Using forceps, the bones were held over a 50 mL conical tube 
(Greiner Bio One, Gloucester, UK) and a 22-gauge needle (ThermoFisher Scientific, Cramlington, 
UK) attached to a 5 mL syringe (ThermoFisher) was inserted into the shaft of the bone and the bone 
marrow (BM) was flushed out with isolation media. The isolation media consisted of Dulbecco’s 
Modified Eagle Medium (DMEM) (Gibco, Cramlington UK) supplemented with 20 % fetal bovine 
serum (FBS) (Gibco), 1 % L-glutamine (ThermoFisher), 1 % Penicillin-Streptomycin (ThermoFisher). 
In total, 20 mL of isolation media was used to flush out the BM into the 50 mL falcon tube. The cell 
suspension was transferred into a new 50 mL falcon tube using a 100 m nylon mesh cell strainer 
(Corning™) to remove bone debris and blood aggregates. The cells were then centrifuged at 200 x 
g, 4 C for 5 minutes and supernatant containing thrombocytes and erythrocytes was aspirated. 
Cells were resuspended in 12 mL isolation media. This was transferred to an adherent petri dish 
(ThermoFisher) and incubated at 37 C and 5 % CO2 in a humidified incubator. This was designated 
as passage 0 (P0). The dishes were left to allow stromal cells (MSCs) to adhere while the non-
adherent haematopoietic cells were removed through media change after two days. The MSCs 
were isolated by their ability to adhere to plastic culture dishes. Media was changed with isolation 
media every 3-4 days.  
 
 
 
 
 
 
Figure 2.1.1 Schematic diagram of the method used to isolate rat MSCs.   
Femur and tibia 
extracted from rat 
Bone marrow is flushed and a 
heterogeneous population of 
cells is collected  
Media changes and cell 
passages will leave only the 
plastic adherent MSCs  
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2.1.2 Passaging MSCs 
After cells reached 70-80 % confluency, MSCs were passaged and designated as passage 1 (P1). 
MSCs were washed in sterile 1 xPBS (5 mL) and incubated with 0.25 % trypsin and 0.1 % EDTA 
(Gibco) (3mL) for 4 minutes at 37 C. Trypsin was then inactivated by adding 7 mL of isolation media 
and centrifuged at 1000 rpm for 3 minutes at 21 C. The supernatant was aspirated, and cells 
resuspended in 1 mL of isolation media and passaged in a 1:3 ratio. After passage 2, the isolation 
media was replaced with MSC culture medium (DMEM, 10 % FBS, L-glutamine (1 %) and Penicillin-
Streptomycin (1%)). The MSC culture medium was then used for routine expansion along with 
passaging in a 1:3 ratio. MSCs was used between passages 2 and 8 for all experiments described.  
 
2.1.3 Reviving frozen MSCs stocks  
Cryovials were quickly thawed by swirling in a 37 C water bath for 1-2 minutes and removed when 
only a small portion of ice remained. The cells were then resuspended with 1 mL of pre-warmed 
MSC culture medium and this was transferred into a 15 mL falcon (Greiner Bio One) containing MSC 
culture medium (8 mL). Cells were centrifuged at 200 x g for 5 minutes, media aspirated off and 
resuspended in 1 mL of media. Subsequently, the cells were seeded 2 x T25 flasks (Greiner Bio One) 
with 5 mL of media in each flask. Media was changed every 3-4 days.  
 
2.1.4 Freezing MSCs cells  
MSCs were frozen down in 1.5 mL cryovials at 1 x 106 cells per mL of freezing media. The freezing 
media consisted of 90 % FBS and 10 % DMSO (Sigma-Aldrich, Dorset, UK). Subsequently, cryovials 
were stored in Mr.FrostyTM Freezing Container (ThermoFisher) at -80 C for 24 hours before being 
moved to long term storage at -150 C.  
 
2.1.5 Flow Cytometry – Cell surface markers 
Flow cytometry was performed to analyse MSC marker expression and to ensure haematopoietic 
markers were not expressed. Cultures were washed in sterile PBS and incubated in trypsin/EDTA 
solution at 37 C for 4 minutes. After cells have detached from the plastic flasks, pre-warmed MSC 
culture medium was added to inactivate trypsin. Cells were collected in a 15 mL falcon and 
centrifuged at 1000 rpm for 3 minutes. The supernatant was aspirated and the cell pellet was 
resuspended in PBS (1 mL) and centrifuged again at 1000 rpm for 3 minutes. This was then repeated 
once more. The cell pellet was then re-suspended in flow buffer (0.1 % Bovine Serum Albumin in 
PBS) (BSA, Sigma-Aldrich). Cells were distributed at 1 x 105 cells per well in flow buffer onto a U-
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bottomed 96-well plate (Greiner Bio-one). 3 wells repeats per antibody was used. A further two 
additional wells were seeded – one containing cells only for adjusting the settings of the flow 
cytometer while the other was for the serum control.  
 
After cells have been seeded appropriately, the plate was centrifuged at 4 C for 3 minutes at 1000 
rpm. The supernatant was removed by flicking the plate over the sink. Cell pellets were then re-
suspended in 50 L primary antibodies (Table 2.1.4). The cell only control well was re-suspended in 
50 L flow buffer and 50 l mouse IgG serum (Sigma) was used for the serum control well. The plate 
was incubated for 1 hour on ice. After this, the plate was centrifuged at 4 C for 3 minutes at 1000 
rpm. Cells were then resuspended in 150 L of flow buffer and centrifuged again at the same 
settings. This was repeated twice more. After three washes in total, all cells were re-suspended in 
50 L secondary antibody (Table 2.1.4) apart from the cell only control which was re-suspended in 
50 L  flow buffer. The plate was wrapped in foil for protection against light and incubated on ice 
for 1 hour. After this, the plate was centrifuged at 4 C for 3 minutes at 1000 rpm. Cells were then 
re-suspended in 100 L of flow buffer and centrifuged again at the same settings. This was repeated 
once more. Following the final wash, cells were re-suspended in 200 L flow buffer and the plate 
was read using Guava Technologies EasyCyte Plus flow cytometer according to manufacturer’s 
instructions.   
 
Table 2.1.5 – Summary of primary and secondary antibodies used in flow cytometry 
Primary and secondary antibodies used in flow cytometry, with their product code, supplier, species and 
isotype. All antibodies were diluted in flow buffer. The expected expression of each marker for MSCs is also 
given.  
Antibody Code Supplier Species  Dilution 
Expected 
expression 
Anti-CD34 
(Primary) 
sc-7324 Santa Cruz Mouse  1 in 100 Negative 
Anti-CD45 
(Primary) 
554875 BD Pharmingen Mouse  1 in 100 Negative 
Anti-CD90 
(Primary) 
554892 BD Pharmingen Mouse  1 in 100 Positive 
Anti-Mouse IgG 
Alexa Fluor 488 
A11001 Invitrogen Goat  1 in 100 N/A 
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2.1.5.1 Analysis of Flow cytometry data and gating  
Raw data was analysed by gating to include only the live cells and minimising the background 
scatter of cells. Plots of the fluorescence in samples was then expressed in histogram form to view 
the distribution of the signal. The mouse serum only control was used to determine levels of 
background fluorescence as the peak indicates the level of non-specific signal (Figure 2.1.4.1). Any 
sample peaks outside the threshold was considered as positive marker expression. Data was also 
shown to include the % gated of cells which is used to quantify the proportion of cells which display 
a positive signal (% Marker expression).  
 
 
 
 
 
 
 
 
 
 
2.1.6 Inducing osteogenic differentiation of MSCs 
To induce osteogenic differentiation of MSCs, a previously established protocol was used132. MSCs 
were seeded onto 6 well plates at 3 x 103 cells/cm2 using MSC culture medium (5 mL). For use in 2D 
staining, cells were seeded onto glass coverslips which were coated overnight at 4 C with 10 gmL-
1 poly-D-lysine (Sigma-Aldrich) before cells were seeded. After 3-4 days when cells have reached 
70-80 % confluency, the cell culture medium was switched to osteogenic medium (MSC culture 
medium supplemented with dexamethasone (100 nM) (Sigma-Aldrich), ascorbic acid 2-phosphate 
(50 M) (Sigma-Aldrich) and β-glycerophosphate (10 nM) (Sigma-Aldrich)). Media was changed 
every 3-4 days and cells were maintained in the osteogenic medium for up to 21 days.   
 
2.1.7 Inducing adipogenic differentiation of MSCs  
To induce adipogenic differentiation of MSCs, a previously established protocol was used132. MSCs 
were seeded onto 12 well plates (Greiner Bio-one) at 2 x 104 cells/cm2 using MSC culture medium 
Figure 2.1.5.1 – Flow cytometric analysis of the serum control well. Representative image of the serum control 
well. The peak is used to gate the levels of background signal. Any signal greater than this was determined as a 
positive signal and therefore a positive marker expression.  
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(2 mL). For use in 2D staining, cells were seeded onto glass coverslips which were coated overnight 
at 4 C with 10 gmL-1 poly-D-lysine (Sigma-Aldrich) before cells were seeded. After 3-4 days when 
cells have reached 70-80% confluency, the cell culture medium was switched to adipogenic 
induction medium (MSC culture medium supplemented with dexamethasone (1 M) (Sigma-
Aldrich), indomethacin (0.2 mM) (Sigma-Aldrich), insulin (10 g/mL) (Sigma-Aldrich) and 3-isobutyl-
1-methylxanthine (0.5 mM) (Sigma-Aldrich)). After 3 days, the adipogenic induction medium was 
removed and replaced with adipogenic maintenance medium (MSC culture medium supplemented 
with insulin (10 g/mL)) (Sigma-Aldrich) for 2 days. This cycle of induction medium for 3 days and 
maintenance medium for 2 days was repeated for 21 days.  
 
2.2 MG-63 
2.2.1 Culturing MG-63 
MG-63 human osteosarcoma cells were obtained from the American Type Culture Collection 
(ATCC). Vials of frozen cells were thawed and revived in the same way as described in Section 2.1.2 
and 2.1.3. Cells were maintained in media containing Modified Eagle Minimum Essential Media 
(MEM) (Gibco) supplemented with 10 % FBS (Gibco), 1 % L-glutamine (ThermoFisher) and 1 % 
Penicillin-Streptomycin (ThermoFisher). When cells reached 70-90% confluency (Figure 2.2.1), cells 
were routinely passaged in a 1:3 – 1:6  ratio using the method previously described in Section 2.1.2. 
Medium was changed every 2-5 days as required. MG-63 cells were used between passages 16 and 
30 for all experiments described. For use in 2D staining, cells were seeded onto glass coverslips 
using a density of 2 x 104 cells/cm2 per 6 well plate.  
 
 
 
 
 
 
 
 
 
  
Figure 2.2.1 – Phase contrast image of MG-63 cells in culture. Representative image of confluent MG-63 before 
passaging. Scale bar = 100 m. Magnification = 20 x.  
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2.3 Alvetex 3D cultures 
2.3.1 Seeding cells into Alvetex membranes 
3 types of Alvetex 3D polystyrene scaffold membranes (ReproCELL Europe, Sedgefield, UK) were 
used in this project. Cells were seeded onto Alvetex Scaffold, Alvetex Strata in the same way. The 
scaffold membranes were dipped in 70 % ethanol for 5 minutes followed by two washes in sterile 
1 x PBS. Alvetex Scaffold/ Alvetex Strata 12-well inserts were placed in 12-well culture plates and 
hydrated by adding 500L of cell culture media to each membrane for a few minutes. Cells were 
harvested using trypsin as previously described Section 2.1.2 and were seeded at a density of 5 x 
105 per 150 L media per membrane. Plates were then incubated at 37 C with 5 % CO2 in a 
humidified incubator for 3 hours. Following this, each insert was topped with 4 mL of the 
appropriate cell culture media with media changes every 3 – 4 days.  
 
Alvetex Polaris 6-well inserts were prepared by clipping the membranes onto the inserts and left 
in 100 % ethanol overnight. The membranes were then dipped in 70 % ethanol followed by two 
washes in sterile 1 x PBS. The inserts were placed into 6-well culture plates and hydrated by adding 
1 mL of cell culture media. Cells were seeded at a density of 1 x 106 per 300 L media per membrane. 
Plates were then incubated at 37 C with 5 % CO2 in a humidified incubator for 3 hours. Following 
this, each insert was topped with 10 mL of the appropriate cell culture media with media changes 
every 3 – 4 days.  
 
For 3D osteogenic differentiation, MSCs were seeded as described previously with MSC culture 
media. After 3-4 days, the medium was replaced with osteogenic differentiation media. This was 
cultured for up to 21 days with media changes every 3 – 4 days.  
 
2.3.2 Fixation of Alvetex 3D scaffolds 
Alvetex scaffold membranes were unclipped from their inserts and washed 2 x with sterile 1 x PBS. 
The PBS was then replaced with 4 % paraformaldehyde (PFA) and samples were fixed for 2 hours 
at room temperature. PFA was removed and washed 2 x with 1 x PBS. Samples were stored at 4 C 
in PBS until further processed.  
 
2.3.3 Paraffin Wax Embedding and Sectioning of Alvetex 3D scaffolds 
For paraffin embedding, PBS was removed and 30 % ethanol was added for 15 minutes. 30 % 
ethanol was replaced with 50 % ethanol for a further 15 minutes. Samples were stained with 0.1 % 
crystal violet (Sigma-Aldrich) in 70 % ethanol for 15 minutes to aid visualisation during sectioning. 
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The crystal violet was removed and samples were dehydrated through 80 %, 90 %, 95 % and 100 % 
ethanol at room temperature for 15 minutes each.  
 
Following dehydration, Alvetex 3D scaffolds were placed into embedding cassettes 
(ThermoFisher) and transferred to a glass beaker containing Histoclear (National Diagnostics, East 
Riding, UK) for 30 minutes at room temperature. Subsequently, samples were transferred to a  glass 
beaker containing a 1:1 mixture of liquid paraffin wax (ThermoFisher) and Histoclear for 30 minutes 
at 60 C. Samples were further incubated at 60 C for 1 hour with liquid paraffin wax only. Scaffolds 
were removed from the cassettes and cut in half and set into paraffin wax using plastic moulds 
(CellPath, Newton, UK) and the top of the cassettes were placed on top of the moulds. Wax blocks 
were then left to solidify overnight.  Alvetex scaffolds embedded into wax blocks were sectioned 
at 6 m using a Leica RM2125RT Microtome and mounted onto charged Superfrost microscope 
slides (ThermoFisher).  
 
2.3.4 Haematoxylin and Eosin Staining 
Slides were deparaffinised in Histoclear for 10 minutes before being rehydrated in a series of 
ethanols: 100 % ethanol for 2 minutes, 95 % ethanol for 1 minute, and 70 % ethanol for 1 minute. 
Samples were then placed in deionised water for 1 minute and stained in Mayer’s Haematoxylin 
(Sigma- Aldrich) for 5 minutes. Following this, slides were rinsed in deionised water for 30 seconds 
and the nuclei were blued in alkaline ethanol for 30 seconds. Samples were then dehydrated with 
70 % ethanol and 95 % ethanol for 30 seconds each before being stained in Eosin solution (Sigma-
Aldrich) for 1 minute. Slides were then rinsed in 95 % ethanol for 10 seconds, followed by another 
rinse in 95 % ethanol for 15 seconds and then dehydrated with 100 % ethanol for 15 seconds and 
another 100 % ethanol for 30 seconds. Clearing of slides involved 2 incubations in Histoclear for 3 
minutes each. Slides were mounted in Omnimount (Scientific Laboratory Supplies, Nottingham, UK) 
and glass coverslips (ThermoFisher). Images were taken using a Leica ICC50HD microscope.   
 
2.4 Histological and fluorescent stains  
2.4.1 Alizarin Red (2D)  
Alizarin Red stain solution was prepared through dissolving 1 g of Alizarin Red S powder (Sigma-
Aldrich) in 50 mL deionised water to make a 2 % solution. The pH of the solution was adjusted to 
4.1 – 4.3 using concentrated hydrochloric acid when the pH needed to be lowered while 10 % 
ammonium hydroxide was used to increase pH. At the appropriate time points, the cells on 
coverslips were washed twice with 1 x PBS and fixed with 4 % PFA for 1 hour at room temperature. 
Glass coverslips were stained with Alizarin Red solution for 2 minutes, dehydrated with acetone, 
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followed by dehydration in 50:50 acetone: Histoclear for a few minutes. Coverslips were then 
cleared in Histoclear for before being mounted using Omnimount (Scientific Laboratory Supplies). 
 
2.4.2 Alizarin Red (3D)  
Alizarin Red stain solution was prepared using the method described in 2.4.1. Slides were 
deparaffinised in Histoclear for 10 minutes, rehydrated in 100 % ethanol for 2 minutes, 95 % ethanol 
for 1 minute, 70 % ethanol for 1 minute and deionised water for 1 minute. Slides were covered in 
Alizarin Red solution for 2-5 minutes and excess dye was shaken off. Slides were then dipped in 
acetone for 20 dips and 50:50 acetone: Histoclear for a further 20 dips. Sections were cleared in 
Histoclear before being mounted using Omnimount (Scientific Laboratory Supplies) and glass 
coverslips.  
 
2.4.3 Nile Red (2D) 
To confirm the adipogenic differentiation of MSCs, the red fluorescent Nile red dye (Sigma-Aldrich) 
was used. Cells were cultured using the method mentioned previously (Section 2.1.6) on glass 
coverslips for 21 days. Glass coverslips were coated overnight at 4 C with 10 gmL-1 poly-D-lysine 
(Sigma-Aldrich) before cells were seeded. Cells were washed in 1 x PBS and fixed with 4 % 
paraformaldehyde (PFA) for 1 hour at room temperature. 1 in 100 dilution of the stain was used 
(diluted in PBS) and glass coverslips were stained with Nile red in the wells for 10 minutes at room 
temperature. The glass coverslips were then washed twice with 1 x PBS and mounted with 
VECTASHIELD® hardset antifade mounting medium with DAPI (Vector Laboratories, Peterborough, 
UK).  
 
2.5 Immunofluorescence Staining 
2.5.1 Immunofluorescence staining of 2D cultures  
Samples on coverslips in 6-well culture plates were washed in PBS and fixed with 4 % PFA for 1 hour 
at room temperature. Cells were permeabilised with 0.1 % Triton-X100 in 1 x PBS for 10 minutes 
and blocked for 30 minutes in blocking buffer. Blocking buffer consisted of 1 % normal goat serum 
(NGS, Sigma-Aldrich) and 0.01 % Tween (Sigma-Aldrich) in PBS. Primary antibody diluted in blocking 
buffer was then added to each sample (Table 2.5.2) and incubated for 1 hour. Coverslips were then 
washed three times with blocking buffer for 10 minutes. Following this, samples were incubated 
with the appropriate fluorescent secondary antibody mixed with nuclear dye Hoechst 33342 
(ThermoFisher) (Table 2.5.2.1) diluted in blocking buffer for 1 hour in the dark. Coverslips were then 
washed with blocking buffer three times for 10 minutes each. After this, samples were mounted 
onto microscope slides using VECTASHIELD® anti-fade mounting medium (Vector Laboratories).  
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2.5.2 Immunofluorescence staining of 3D cultures  
Paraffin wax sections of samples were first deparaffinised in Histoclear for 10 minutes, rehydrated 
in 100 % ethanol, 70 % ethanol and 1 x PBS for 5 minutes each. Subsequently, samples were 
incubated in a 95 C water bath with citrate buffer for 20 minutes for retrieval antigens. The slides 
were then slowly cooled to room temperature as the citrate buffer was gradually replaced with 
deionised water. A hydrophobic pen (Liquid blocker) was used to draw around samples on slides. 
Samples were then incubated in blocking buffer containing 20 % NGS and 0.4 % Triton X-100 diluted 
in 1 x PBS for an hour at room temperature. After this, samples were incubated overnight at 4 C 
with primary antibody diluted in blocking buffer(Table 2.5.2). Samples were then washed three 
times in 1 x PBS for 5 minutes each and incubated with secondary antibody mixed with Hoeschst 
(Table 2.5.2.1) diluted in blocking buffer for an hour at room temperature in the dark. Slides were 
then washed three times in 1 x PBS for 5 minutes each before mounting with glass coverslips using 
VECTASHIELD® anti-fade mounting medium. Negative control of immunofluorescence staining of 
3D cultures is shown in Figure 2.5.2. Cells were cultured on Alvetex scaffold and Hoechst antibody 
was used to stain the nuclei blue.  
 
 
 
 
 
 
 
 
 
 
 
Table 2.5.2 – Primary antibodies used in immunofluorescence 
Summary table of the primary antibodies used in immunofluorescence of 2D and 3D samples, with their 
respective product code, supplier and host species. All antibodies were diluted in blocking buffer.  
Target Code Supplier Host Species Dilution 
Collagen I ab34710 Abcam Rabbit 1:100 
Collagen III ab7778 Abcam Rabbit 1:100 
Fibronectin ab23750 Abcam Rabbit 1:100 
 
 
 
 
 
Figure 2.5.2 – Negative control of cells cultured on Alvetex Scaffold. Representative image of background staining 
of immunofluorescent staining of cells cultured on Scaffold. Only Hoechst staining of nuclei is shown.  Scale bar = 100 
m. Magnification = 20 x.  
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Table 2.5.2.1 – Secondary antibodies and dyes used in immunofluorescence 
Summary table of the secondary fluorescent conjugated antibodies and nuclear dye used in 
immunofluorescence of 2D and 3D samples. The respective product code, supplier and emission wavelengths 
are given. All antibodies were diluted in blocking buffer.  
Antibody Code Supplier 
Emission 
Wavelength 
Dilution 
Alexafluor 
anti-rabbit 488 
A32790 ThermoFisher 488 1:1000 
Hoechst 33342 H3570 ThermoFisher 461 1:1000 
 
2.5.3 Cell counting using ImageJ analysis  
In order to quantify the amount of cell nuclei in 3D cultures, cultures were stained with Hoechst as 
previously described. Hoechst immunofluorescently stains nuclei in samples. Digital images of the 
stains were taken using confocal microscopy and analysed using ImageJ (https://imagej.net), which 
is a software package used commonly for image processing. The software comes with a “Cell 
Counter” plugin located under Plugins> Cell counter which is a way of getting an indication of the 
numbers of cells in an image. Three representative images at the same magnification (20 x) and 
area of each cell type and timepoint was used. Each image was converted to 8-bit to make it easier 
to distinguish between nuclei and the scaffold as nuclei is displayed as white. Each nucleus in the 
image was clicked on directly to count it using the cell counter window. The average number of 
cells per cell type/time point was calculated and plotted in a bar chart with the standard error of 
the mean (SEM) bars. Example is shown in Figure 2.5.3.  
 
 
 
 
 
 
 
 
 
 
  Figure 2.5.3 – Quantification of the number of cells in 3D samples was performed using ImageJ. The in-built cell 
counter function of the ImageJ processing software was used to count the number of nuclei (white) in each 
representative sample.  
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2.6 Alkaline Phosphatase Assay   
2.6.1 Running the alkaline phosphatase assay 
The level of extracellular alkaline phosphatase (ALP) in cultures was measured as an early marker 
of osteoblastic differentiation. The assay was performed using the alkaline phosphatase 
colorimetric assay kit (Abcam, Cambridge, UK) according to the protocol provided by the 
manufacturer. The kit uses p-nitrophenyl phosphate (pNPP) as a phosphate substrate for the ALP 
enzyme. During this hydrolysis reaction, ALP dephosphorylates pNPP to produce p-nitrophenol 
which yields a yellow substrate which can be measured spectrophotometrically at 405 nm. The level 
of ALP activity in the samples is therefore directly proportional to the absorbance measured.  
 
MSCs were cultured under osteogenic conditions for 7, 14 and 21 days on 6-well plates (2D) vs 
Alvetex Scaffold (3D). For MG-63s, cells were cultured using their complete culture medium on 6-
well plates (2D) vs  Alvetex Scaffold (3D) for the same time points. The cell culture medium was 
collected during the last day of experimental culture for each sample. The experimental samples 
were prepared through diluting by 1:1 for MSCs samples while MG-63 samples were diluted by 1:5 
with ALP assay buffer. The samples were prepared in duplicates and sample background control 
was included using normal culture medium to minimise the interference of the coloured samples. 
50 L of 5 mM pNPP solution was added to sample and sample background controls and incubated 
in the dark for 60 minutes. Standards of known concentrations of p-nitrophenol was included for 
the construction of a standard curve. Absorbance was measured at 405nm using a BioTek, ELx800 
microplate reader.  
 
2.6.2 Calculating the concentration of Alkaline Phosphatase activity in samples 
The concentration of ALP in samples was calculated through a series of steps:  
1. Background was corrected through subtracting the absorbance value from the zero standards 
from all readings  
2. Sample background control value was subtracted from all sample readings and the average of 
the duplicate absorbance readings for each sample was calculated 
3. A standard curve from the standard control values was plotted using GraphPad Prism software 
An example is shown in Figure 2.6.2.  
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4. The equation of the line was calculated and the X value (amount of pNPP in sample) was obtained 
by substituting the Y value (absorbance) for each sample.  
5. The ALP activity of each sample was calculated using the following formula provided by the assay 
kit:  
𝐴𝐿𝑃 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 = (
𝑋
∆𝑇 ×  𝑉
) ×  𝐷 
Where:  
𝑋 = amount of pNPP in sample calculated from standard curve (mol) 
∆𝑇 = reaction time (minutes) (60 minutes) 
𝑉 = volume of sample added to the assay well (mL)  
𝐷 = sample dilution factor 
6. ALP activity was normalised to total protein content for each sample (as determined by the 
Bradford assay) (Section 2.7).   
 
2.7 Bradford Protein Assay  
A Bradford Assay was used to quantify the total protein content of osteogenic-induced MSCs and 
MG63s cultured on 6-well plates (2D) vs Alvetex Scaffold (3D) for 7,14 and 21 days. At the end of 
each culture period, cell lysates from each time point and condition was generated.  
 
2.7.1 Generation of Cellular Lysates – 2D cultures 
2D cultures on 6-well plates were washed in PBS and trypsinised with  0.25 % trypsin and 0.1 % 
EDTA (Gibco) (3 mL) for 4 minutes at 37C. Trypsin was then inactivated by adding 7 mL of isolation 
media and centrifuged at 1000 rpm for 3 minutes at 21 C. The number of viable cells in the sample 
was counted using a sample of the cell suspension (10 L) and trypan blue solution (10 L) (Sigma 
Aldrich). Cell number was determined using a haemocytometer and diluted to a concentration of 
Figure 2.6.2 – Example of standard curve for calculating ALP levels in samples 
A typical standard curve plotting the absorbance at 405 nm against the Standards of known 
concentrations of p-nitrophenol. A linear regression graph was plotted to obtain the equation of 
the line which is used to determine the concentration of ALP in samples.  
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100,000 cells in 1 mL media. The cells were then centrifuged at 1000 rpm for 3 minutes at 21 C 
and the cell pellet was dissolved in 100 L lysis buffer containing 1 % protease inhibitor cocktail 
(Sigma-Aldrich) diluted in Mammalian Protein Extraction Reagent (MPER™, ThermoFisher). 
Samples were sonicated for 30 minutes and centrifuged at 12000 rpm for 20 minutes at 4 C. The 
supernatant was then collected and frozen at -20 C until use.  
 
2.7.2 Generation of Cellular Lysates – 3D cultures 
Alvetex Scaffold membranes were unclipped from their inserts and washed 2 x with sterile 1 x PBS. 
The membranes were then placed in 100 L of lysis buffer and sonicated for 30 minutes. 
Subsequently, samples were centrifuged at 12000 rpm for 20 minutes at 4 C and the supernatant 
was then collected and frozen at -20 C until use.  
 
2.7.3 Running the Bradford assay 
The protein standards (0.125 to 2.0 mgmL-1) for the assay was prepared by adding 5 L of each BSA 
Protein Standards (Bio-Rad, Hertfordshire, UK) and 250 L of Quick Start™ Bradford 1x Dye Reagent 
(Bio-Rad) to a 96-well flat-bottomed plate. This is for producing a standard curve to determine the 
concentration of protein for each sample. A well containing deionised water only was used as a 
blank. For running the assay, lysates were thawed on ice and 5 L of each sample were pipetted 
onto a well along with 250 L of Bradford Reagent. Each sample was read in triplicate. The plate 
was then incubated for 5 minutes and the absorbance was read at 590 nm using a BioTek ELx800 
microplate reader.  
 
2.7.4 Quantifying protein content  
The absorbance for each sample was calculated by subtracting the blank values from the average 
absorbance value of each sample. A standard curve was plotted using GraphPad Prism software 
using the absorbance from the protein standards. The equation of the line was calculated from the 
standard curve and the protein concentration was calculated (x value) through substituting the 
absorbance (y value) for each sample.  
 
2.8 Western Blot 
2.8.1 Gel casting – SDS Polyacrylamide Gel Electrophoresis 
30 g/mL of protein lysates samples were prepared by diluting the sample in 4x Laemmli sample 
buffer (Bio-Rad) and 10 % 2-mercaptoethanol (Sigma-Aldrich). Subsequently, samples were boiled 
at 95 C for 10 minutes using a heat block. Samples were loaded into polyacrylamide gels along 
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with a protein ladder (ThermoFisher) and run at 120 V for 2 hours in 1 x running buffer (Bio-Rad). 
This SDS-PAGE (sodium dodecyl sulphate- polyacrylamide gel electrophoresis) is the first stage of 
Western blotting for resolving proteins by molecular weight. The components used to make up the 
gels for running the samples are listed in Table 2.8.1  
 
Table 2.8.1 –  Components used to make SDS-PAGE gels and Western blot membranes 
Summary table with all the components used to make the stacking and resolving gels used to run 
the samples and the manufacturers of each component.  
Type of Gel Components 
5 % Stacking Gel ▪ 5 % ProSieveTM 50 Gel Solution (Acrylamide) (Lonza, Basel, 
Switzerland) 
▪ 1.5 M Tris, pH 6.8 (ThermoFisher) 
▪ 10 % Sodium dodecyl sulfate (SDS) (ThermoFisher) 
▪ 10 % Ammonium Persulfate (APS) (ThermoFisher) 
▪ 0.1 % N,N,N,N’-tetramethylethane-1,2-diamine (TEMED) 
(Sigma-Aldrich) 
8 % Resolving Gel ▪ 8 % ProSieveTM 50 Gel Solution (Acrylamide) 
▪ 1.5 M Tris, pH 8.8 
▪ 10 % SDS 
▪ 10 % APS 
▪ 0.1 % TEMED 
 
2.8.2 Protein transfer  
The proteins on the gel were transferred from the polyacrylamide gel to a nitrocellulose membrane 
(GE Healthcare, Buckinghamshire, UK) by first discarding the stacking gel and sandwiching the 
resolving gel in the following order onto a transfer cassette: sponge, blotting paper, stacking gel, 
nitrocellulose membrane, blotting paper and sponge. The transfer cassette was then placed in a 
transfer tank topped with transfer buffer (3.03 g Tris, 14.41 g glycine, 200 mL methanol topped with 
1 L of deionised water). The transfer was run at 15 V at 4 C overnight and a further 2 hours at 30 
V the following day. As the transfer was run overnight, the electrical current was around 0.4 Amps 
and the current was kept constant.  
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2.8.3 Ponceau staining 
To check if the proteins did successfully transfer onto the membrane, the membrane was incubated 
in Ponceau S solution (Sigma-Aldrich) for 5 minutes. The membrane was then washed with 
deionised water several times and the bands were clearly evident on the membrane, indicating a 
successful transfer.  
 
2.8.4 Blocking and Immunostaining of membrane 
The membrane was blocked in 5 % milk powder (Sainsbury’s, London, UK) dissolved in 0.1 % Tween 
in PBS. This was to prevent non-specific background binding. The membrane was then incubated in 
primary antibodies (Table 2.8.4) diluted in 5 % milk solution overnight at 4 C on a rotator. Following 
this, the membrane was washed 3 times for 5 minutes each in 0.1 % Tween in PBS and incubated 
in secondary antibody (Table 2.8.4 ) diluted in 5 % milk solution. This was left for an hour at room 
temperature. The membrane was washed a further 3 times for 5 minutes in 0.1 % Tween in PBS.  
 
Table 2.8.4 – Antibodies used in western blotting 
Primary and secondary antibodies used in western blot. All secondary antibodies were conjugated 
with horseradish peroxidase (HRP) which allows for chemiluminescence detection.  
Target Code Supplier Host Species Dilution 
 - actin Ab8224 Abcam Mouse 1:5000 
Collagen I 1310 - 01 
Southern 
Biotech 
Goat 1:1000 
Anti-goat-HRP AP180P Sigma-Aldrich Donkey 1:10000 
Anti-mouse-HRP A4416 Sigma-Aldrich Goat 1:10000 
 
2.8.5 Blot development 
The Clarity ECL (Enhanced chemiluminescence) solution (Bio-Rad) was prepared by adding the two 
solutions supplied in a 1:1 ratio following manufacturer’s instructions. 1 mL of ECL was then added 
to the membrane for detection and the membrane was developed through exposure with 
photographic film (ThermoFisher) in a dark room using a film processor (XOMAT).  
 
2.9 Microscopy  
2.9.1 Phase contrast microscopy  
Phase contrast images were taken using EVOS XL Core Cell Imaging system microscope. The 
objective lenses x10, x20 and x40 were used.  
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2.9.2 Brightfield Imaging 
Histological samples were imaged using a Leica ICC50 High Definition camera mounted onto a Leica 
microscope. The objective lenses x10, x20 and x40 were used. Images were captured using Leica EZ 
software.  
2.9.3 Confocal microscopy  
Confocal fluorescent images were captured using Zeiss 800 confocal laser-scanning microscope 
with airyscan. The objective lenses x10, x20 and x63 were used. Zeiss Zen software was used to take 
the images.  
 
Table 2.8.5 – Technical information for secondary antibody labels 
Technical settings for each secondary antibody used during confocal microscopy. 
Antibody 
Excitation 
Wavelength/nm 
Emission 
Wavelength/nm 
Airy value 
(AU) 
Laser 
wavelength 
Alexafluor 
anti-rabbit 488 
488 525 1 488 
Hoechst 33342 350 461 1.2 405 
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3. Results 
3.1 Isolation and characterisation of primary rat MSCs  
3.1.1 Cells isolated from rat bone marrow display MSC morphology  
MSCs were isolated from the femur and tibiae of Wistar rats as previously described in Section 
2.1.1. Plastic adherence of cells to the culture flask was used to select for MSCs as the other cell 
types in the bone marrow, mainly hematopoietic cells do not possess this characteristic. As a result, 
with increasing media changes and passages, only true MSCs will be left in cultures while non-plastic 
adherent cells were washed away. Figure 3.1.1 illustrates the MSCs at different stages during the 
isolation and passaging process. A heterogenous population of cells of varying morphologies from 
the bone marrow was collected (Figure 3.1.1A). By day 4 (Figure 3.1.1B), a small population of cells 
began to differentiate and displayed a long, spindle-shaped morphology (arrowheads) which is in 
keeping with cells of MSC origin. However, contaminating haematopoietic cells which display a 
small and round morphology remained. After 9 days (Figure 3.1.1C), the majority of non-adherent 
cells were removed and MSCs increased in proliferation and expansion. At later time points, MSCs 
maintained a homogenous fibroblastic morphology which is in agreement of cells of MSC origin 
(Figure 3.1.1D – F). When cultures reached 70 – 80% confluency (Figure 3.1.1E), which was around 
10-13 days after initial plating of bone marrow cells, cells were passaged using methodology 
previously described (Section 2.1.2) and designated P1. Cells used in experiments were between P2 
and P8, whereby the vast majority of cells displayed plastic adherence and fibroblast-like 
morphology, indicating the cells isolated were of MSC origin.  
 
3.1.2 Cell surface marker expression of isolated cells are negative for haematopoietic markers 
and positive for MSC marker 
Flow cytometry analysis was used to further confirm the cells isolated and used in downstream 
experiments were of MSC origin. Two haematopoietic markers (CD34 and CD45) and one MSC 
marker (CD90) was used to assess the purity of the isolated cells. Expression of CD34 and CD45 was 
largely negative (Figure 3.1.2A-B,D) which indicates cultures used in experiments were not/very 
minimally contaminated with haematopoietic cells. Although no single definitive marker has been 
found to be unique for MSCs, there are several cell surface marker antigens which have been widely 
used to characterise MSCs such as CD90. Expression of CD90 was largely positive (Figure 3.1.2C-D), 
suggesting the cells obtained from the isolations were of MSC origin.   
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Figure 3.1.1 –  Isolation of rat MSCs and expansion process. Phase contrast images showing the cells isolated from rat bone marrow. A heterogenous population of 
cells can be seen in day 1 (A) and day 4 (B). MSCs are selected for through plastic adherence. By day 9 (C) after several media changes and passages, a more 
homogenous population of cells remain. As time increases (D – F), MSCs display a large, flattened, fibroblast- like morphology. The passage numbers for each culture 
is also shown. Scale bars (A – D), (F) = 100 m, E = 200 m.  
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3.1.3 Isolated MSCs demonstrate the ability to differentiate into multiple mesodermal cell types 
such as osteogenic and adipogenic in 2D culture 
As shown in previous sections, the isolated cells from the bone marrow display MSC morphology, 
are negative for haematopoietic cell surface markers and are positive for MSC markers. Another 
approach to test whether the cells isolated are true MSCs is through assessing their multilineage 
differentiation potential into mesodermal derivatives such as bone and fat. This is the key 
characteristic of true MSCs.  
 
Following the method described in Sections 2.1.6 and 2.1.7, MSCs were induced to undergo 
osteogenic and adipogenic differentiation for up to 21 days. MSCs cultured under osteogenic 
conditions were assessed using the Alizarin Red histological stain. Deposits of calcium in the 
extracellular matrix are stained red which is highly indicative of calcified bone nodule formation. 
Figure 3.1.3A display positive Alizarin Red staining of cells cultured under osteogenic conditions as 
cells were able to form multiple calcified deposits and displayed cell condensation, suggesting the 
formation of bone nodules in cultures. Negative controls were stained simultaneously which 
consisted of cells cultured under MSC culture medium without osteogenic morphogens and this 
displayed little evidence of positive staining or bone nodule formation (Figure 3.1.3B).  
Figure 3.1.2 – Flow cytometric analysis of cell surface marker expression of isolated cells. 
Representative images displaying the cell surface marker expression for haematopoietic (A – B) and 
MSC (C) markers of isolated cells. Haematopoietic marker expression was largely negative while 
MSC marker was very positive. Stained cells are represented in green while the serum control 
(negative control) is in red. Results of % marker expression over three independent repeats are 
shown in (D). Data represent the mean ± SEM (n= 3).  
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MSCs cultured under adipogenic conditions were assessed using the fluorescent lipophilic Nile red 
stain. Nile red staining of isolated cells showed intense red globular structures inside cells, 
resembling intracellular lipid droplets (Figure 3.1.3C). Evidence of lipid droplets was observed 
from day 7. Negative controls containing MSCs grown using normal MSC culture media did not 
display any positive staining (Figure 3.1.3D).  
 
The main characteristic of stem cells is the ability to differentiate into multiple cell lineages, 
therefore by demonstrating that the isolated cells are able to differentiate into mature 
mesodermal lineages suggest they are true mesenchymal stem cells. Characterising the isolated 
cells via plastic adherence, morphology, cell surface marker expression and differentiation 
potential suggests the cells used in further downstream experiments were true MSCs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.1.3 – Isolated MSCs display multilineage differentiation potential. MSCs cultured under 
osteogenic conditions in 2D conventional culture (A) display positive Alizarin Red staining and cell 
condensation, indicative of the early stages of bone differentiation. MSCs cultured under 
adipogenic conditions display positive Nile red fluorescent staining, showing clearly formation of 
lipophilic droplets (C). Control MSCs grown using basic medium with no osteogenic morphogens 
and stained using Alizarin Red (B) and Nile red (D) show negative staining. Scale bars A and B = 
200 m, D = 100 m, C = 50 m.  
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3.2. Selection of the appropriate 3D growth substrate for bone forming cells 
3.2.1 3D cell culture is able to support the growth of MG-63 osteoblast-like cell line 
To test whether 3D cell culture would be able to support the growth and proliferation of bone 
forming cells, cells from the human osteosarcoma cell line MG-63 were seeded onto Alvetex 
Scaffold for up to 28 days. Since MG-63 cells have a quicker growth rate and are easier to culture 
compared to primary MSCs, MG-63 cells were first cultured on the 3D scaffold as a preliminary test. 
Using H&E staining, samples were analysed at day 7, 14,21 and 28 and showed homogenous growth 
throughout the scaffold at all time points (Figure 3.2.1). As MG-63s are osteoblast-like cells, this 
suggests that the 3D cell culture scaffold was able to support the proliferation and growth of bone 
forming cells as healthy cultures were able to be maintained for up to 28 days.  
 
 
 
 
 
3.2.2 The void size differences between the three formats of Alvetex 
Alvetex is available in three different formats which differ in void size and architecture, allowing 
for greater range in applications. Scanning electron micrographs (SEM) demonstrate the differences 
in void and interconnect distribution in the three formats (Fig 3.2.2). Scaffold is the most widely 
used format and contains the biggest voids (40 m) linked by 15 m interconnects. Strata consists 
of 15 m voids linked by 5 m interconnects while Polaris contains the smallest voids at 3 m with 
1 m interconnects (not commercially available). The values were reported by ReproCell Europe 
Ltd.  
Figure 3.2.1. Histological analysis shows Alvetex Scaffold supports the proliferation and 
growth of MG-63 cells. Cells from the human osteosarcoma MG-63 cell line was seeded at 
5x10
5
 cells per 12-well insert of Alvetex scaffold. Cultures were maintained up to 28 days. 
Cells showed homogenous growth throughout the scaffold at all time points. Scale bar = 200 
m.   
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3.2.3 Scaffold is the most appropriate 3D material for MSCs and MG-63 proliferation 
To determine which is the most appropriate format of Alvetex to use for cultivating bone forming 
cells, MSCs and MG-63s were cultured on all three formats for 14 days and compared. Cells were 
seeded at 5 x 105 per 12-well insert of Scaffold and Strata, and 1 x 106 per 6-well insert of Polaris. 
Histological analysis of samples showed the distribution of cells inside the scaffolds (Figure 3.2.3). 
H&E analysis illustrated how MSCs and MG-63 were able to proliferate and grow throughout 
Scaffold and Strata (Figure 3.2.3 A-D). However, for both cell types, the cells were not able to enter 
the Polaris scaffold and instead formed a layer of cells on the top of the membrane (Figure 3.2.3E-
F). This is due to the size of the cells being too large to enter the membrane. MSCs in vivo grow 
throughout the pores of the bone marrow, therefore Polaris was not considered as an appropriate 
material for cultivating bone forming cells as the cells were not able to grow in the membrane. 
Scaffold and Strata were considered as more appropriate materials for recapitulating the in vivo 
environment of bone forming cells. This is due to the cells displaying homogenous growth 
throughout both membranes which is comparable to in vivo conditions. Although the same seeding 
densities were used for Scaffold and Strata, for both MSCs and MG-63s, cells were more densely 
packed and covered a greater area of Scaffold compared to Strata. This indicates Scaffold provides 
a better microenvironment for MSCs and MG-63s as greater proliferation occurred in Scaffold than 
Strata. Scaffold provides a greater surface area for cells to expand on as cell-cell contact inhibition 
of growth is minimised, therefore greater proliferation of cells can occur.
Figure 3.2.2 Scanning electron micrographs of the three formats of Alvetex. The three formats differ 
in their void sizes. Images provided by ReproCell Europe Ltd. Scale bar = 200 m 
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Figure 3.2.3 Histological analysis of culturing MSCs and MG-63s on three formats of Alvetex. MSCs and MG-63s were seeded onto Alvetex Scaffold, Strata and Polaris for 14 days. 5 x 10
5 
cells were seeded onto Scaffold and Strata while 1 x 10
6
 cells were seeded onto Polaris. Cells cultured on Scaffold displayed clearly the greatest homogenous growth and proliferation out of 
all three membranes for both cell types. Scale bar = 100 m.  
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3.2.4 Optimisation of cell seeding density on Scaffold - MSCs 
To determine the number of cells needed for each Scaffold insert which yields the greatest number 
of viable cells, MSCs and MG-63 cells were cultured for 7 and 14 days at densities ranging from 0.25 
to 1 million cells per well. Visualisation of MSCs using H&E analysis (Figure 3.2.4) displayed clearly 
that as time increased (Day 7 to Day 14), the greater the proliferation of cells at each seeding 
density. Cells maintained at 0.25 million resulted in the least growth across the Scaffold and was 
therefore deemed as too low (Figure 3.2.4 A and E). At 1 million cells per well (Figure 3.2.4 D and 
H), MSCs did not populate the Scaffold as much compared to 0.5 million (Figure 3.2.4 B and F) and 
0.75 million (Figure 3.2.3 C and G). At the end of each culture period at 1 million cells/well, the 
media was coloured orange (data not shown). This suggests that 1 million cells/well was too high 
as it is likely that much cell death occurred and therefore a healthy culture could not be maintained. 
The seeding densities 0.5 million and 0.75 million displayed the best homogenous growth 
throughout the Scaffold and healthy cultures could be maintained for up to 14 days. During 
expansion in flasks, MSCs were found to be difficult to culture as on average, only 3 million cells 
could be obtained from a T175 flask (data not shown). This increased the difficulty of setting up 
large scale experiments. Due to this, 0.5 M was determined as the optimum seeding density as it 
produced a homogenous growth of cells throughout the Scaffold and is feasible for large scale 
experiments. This density was used for further experiments.  
 
 
Figure 3.2.4 H&E staining of MSCs seeded on Alvetex Scaffold at a range of densities. MSCs 
were seeded at a range of seeding densities at 0.25 million to 1 million for 7 and 14 days. 0.5 
million was determined to be the optimal density for cell proliferation and feasibility. Scale bar = 
100 m.  
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3.2.5 Optimisation of cell seeding density on Scaffold – MG63s 
MG-63s were seeded in a range of 0.5 to 1 million per 12-well insert of Alvetex Scaffold to 
determine the optimal seeding density. From the H&E images (Figure 3.2.5), 1 million cells per well 
produced the least proliferation of cells at both Day 7 and Day 14. As MG-63 cells are from a cell 
line, the growth rate of cells is rapid and is able to reach confluency quickly. When seeding 1 million 
cells/well, it is likely that the cells did not have enough space to expand and cell-cell contact 
inhibition prevented further proliferation (Figure 3.2.5C,F) This was evident in the media of the 
cultures turning orange very quickly (data not shown), which resembles what was seen with MSCs 
(Figure 3.2.4D,H). Similar to MSCs, 0.5 million cells (Figure 3.2.5A,D) per well produced the greatest 
proliferation of cells in the scaffold and the colour of the media remained red, indicating a healthy 
culture. This resulted in 0.5 million cells/well being used for further experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.6 Pore sizes of scaffold affects osteogenic proliferation of MSCs  
Osteogenic-induced MSCs were cultured on Scaffold and Strata to examine whether porosity of the 
scaffold affects their proliferation. MSCs were seeded onto Scaffold and Strata following the 
methodology previously described and cultured for 21 days (Section 2.3.1). Histological analysis of 
cells revealed clear differences between osteogenic-induced MSCs cultured on Scaffold (Figure 
3.2.6A) compared to Strata (Figure 3.2.6B). The osteogenic-induced MSCs cultured on Scaffold 
produced widespread coverage of the entire membrane and cells were much more elongated and 
numerous. There were also indications of the production of extracellular matrix around the cells 
Figure 3.2.5 H&E staining of MG-63s seeded on Alvetex Scaffold at a range of densities. MSCs 
were seeded at a range of seeding densities at 0.5 to 1 million for 7 and 14 days. Likewise to 
MSCs, 0.5 million was determined to be the optimal density for cell proliferation. Scale bar = 100 
m.  
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cultured on Scaffold, seen on the image as wisps of light purple (ECM) around the dark purple 
(nucleus) which is not seen in Strata. This suggests the larger pores of the Scaffold membrane 
(Figure 3.2.3)  provides a microenvironment which is more conducive to osteogenesis of MSCs as a 
significant stage of differentiation is the secretion of the ECM. Another key reason why Scaffold 
may provide a more suited environment for osteogenesis is that MSCs are able to achieve greater 
proliferation compared to Strata. This is important as the switch to osteogenic differentiation media 
for MSCs occurs 3 days after seeding of cells, therefore if MSCs are able to proliferate more, there 
will be more cells for the next stages of osteogenesis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All results indicate MSCs, osteogenic-induced MSCs and MG-63 cells cultured on Scaffold produced 
greater proliferation, coverage of the membrane and homogenous growth compared to Strata and 
Polaris. Osteogenic-induced MSCs for 21 days cultured on Scaffold were able to secrete ECM which 
is required in order for osteogenic differentiation to take place. Using these results, Alvetex 
Scaffold was determined as a suitable 3D cell culture material for culturing bone forming cells.  
 
Figure 3.2.6 Histological analysis of osteogenic-induced MSCs cultured on Scaffold vs Strata. MSCs 
were seeded onto 12-well inserts of Scaffold and Strata and induced to osteogenic differentiation for 
21 days. Osteogenic-induced MSCs showed greater proliferation and secretion of extracellular matrix 
(arrows) on Scaffold compared to Strata. Scale bar = 100 m.  
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3.3 Characterisation of osteogenesis by bone forming cells cultured in 2D vs Alvetex 
Scaffold 
The process of osteogenesis by osteoprogenitor cells can be split into 3 stages. These stages were 
investigated between 2D and 3D culture methods. These stages are:  
• Proliferation  
• ECM deposition  
• Matrix mineralisation  
 
3.3.1A Proliferation  
Proliferation of bone forming cells is the first stage of osteogenesis. During this stage, progenitor 
cells proliferate and undergo cell division to increase the number of cells in culture. Proliferation 
must occur before differentiation can take place. 
  
3.3.1. Confluency of proliferation of osteogenic-induced MSCs and MG-63s in 3D is reached at 
Day 7  
MSCs were seeded onto Alvetex Scaffold and induced for osteogenic differentiation for up to 21 
days. H&E analysis shows osteogenic-induced MSCs cultured for 7, 14 and 21 days (Figure 3.3.1). 
All three timepoints produced similar results whereby cells demonstrated homogenous growth 
throughout the Scaffold and there were no obvious differences in cell numbers, suggesting 
proliferation remained at similar levels. This is also reflected in the graph (Figure 3.3.1D) displaying 
the cell nuclei counts from each timepoint using the method described in Section 2.5.3 . Counts did 
not produce any statistically significant results between timepoints, suggesting the number of cells 
remained at similar levels. These results indicate that by day 7, osteogenic-induced MSCs reach 
their maximum proliferative capacity and subsequently, begin their differentiation stages. This is 
similar in the osteoblast-like cells MG-63s (Figure 3.3.1.1) which represent a population of 
osteoblast-like cells which are thought to be more mature. In order for cells to differentiate, 
proliferation must be reduced. Culturing MG-63s on Alvetex Scaffold did not show an obvious 
difference in cell numbers between 7,14 and 21 days from H&E analysis or nuclei cell counts (Figure 
3.3.1.1). This suggests the maximum proliferation of cells was achieved by day 7 as the cells 
appeared to have stopped replicating as they have already differentiated into more mature 
osteoblasts.  
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Figure 3.3.1 Osteogenic-induced MSCs cultured on Alvetex Scaffold. MSCs were seeded onto Scaffold and induced for osteogenic differentiation for up to 21 days and their 
proliferation was examined. No obvious differences in cell number was seen across the three timepoints. Scale bar = 100 m. (D) Quantitative analysis of the nuclei number 
at each time point using ImageJ software cell counter. No statistically significant difference was found between the timepoints (P>0.05) . Data represent the mean ± SEM (n= 
3).  
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Figure 3.3.1.1 MG-63s cultured on Alvetex Scaffold. MG-63s were seeded onto Scaffold for up to 21 days and their proliferation was examined. No obvious differences in cell 
number was seen across the three timepoints (A-C). Scale bar = 100 m. (D) Quantitative analysis of the nuclei number at each time point using ImageJ software cell counter. 
No statistically significant difference was found between the timepoints (P>0.05) . Data represent the mean ± SEM (n= 3).  
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3.3.2A ECM deposition  
ECM formation is a marker of MSC commitment and differentiation to osteoblasts following 
proliferation, and this was compared in 2D and 3D cultures. As seen previously in Figure 3.2.6, 
secretion of ECM by osteogenic-induced MSCs cultured using Alvetex Scaffold can be observed. 
The following section aimed to characterise the osteogenic markers found in the synthesised ECM. 
The 4 markers tested in this project are: fibronectin, collagen I, collagen III and alkaline 
phosphatase.  
 
3.3.2 ECM deposition – Fibronectin  
A major component of the ECM which is highly expressed in bone ECM is fibronectin, particularly 
during the early stages of osteogenesis. Fibronectin was also deposited in areas of recruitment and 
commitment of osteoblast precursors, which is involved during formation of mesenchymal 
condensations, indicative of bone nodule formation.  
 
3.3.2.1 Fibronectin is secreted around condensations  by osteogenic-induced MSCs in 2D culture 
Immunofluorescence was used to analyse the synthesis of fibronectin by 2D cultures of osteogenic-
induced MSCs, up to day 21 (Figure 3.3.2.1). Mesenchymal condensations can be seen by day 7 
(Figure 3.3.2.1A), indicating bone nodule formation. With time, the mesenchymal condensations 
become larger as more cells are recruited and osteogenic-induced MSCs progressively 
differentiates into osteoblasts (Figure 3.3.2.1A-C). Interestingly, fibronectin secretion is localised to 
areas in the borders around the mesenchymal condensations formed by osteogenic-induced MSCs 
and not inside the nodules (Figure 3.3.2.1A-C). In the negative controls of MSCs cultured without 
osteogenic morphogens, fibronectin is secreted between cells and links are formed using 
fibronectin (Figure 3.3.2.1D-F). This is suggested to be MSCs secreting fibronectin to locate other 
cells to actively migrate and come together, resulting in indications of cell condensations by day 21 
(Figure 3.3.2.1F). This indicates that rat MSCs may spontaneously differentiate into cells of 
osteogenic lineage by day 21, without induction by osteogenic morphogens. 
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3.3.2.2 Fibronectin secretion decreases with time in 3D cultures of osteogenic-induced MSCs  
To investigate fibronectin secretion of osteogenic-induced MSCs in 3D culture, MSCs were seeded 
onto Alvetex Scaffold and cultured under osteogenic conditions for up to 21 days. Images from 
immunofluorescence analysis revealed decrease in fibronectin synthesis of osteogenic-induced 
MSCs from day 7 to day 21 (Figure 3.3.2.2A-C). At day 7, fibronectin production is very evident and 
occurs throughout the Scaffold (Figure 3.3.2.2A). However, by day 14 (Figure 3.3.2.2B), smaller 
amounts of fibronectin are deposited in cultures and becomes concentrated at the top and bottom 
layers of the Scaffold by day 21 (Figure 3.3.2.2C). Fibronectin is involved in early stages of 
osteogenesis, which suggests that as time in culture progresses, osteogenic-induced MSCs are 
differentiating into more mature osteoblasts. By day 14 and 21, later stages of osteogenesis occur 
which results in the decline in fibronectin production by the osteogenic-induced MSCs. 
 
Figure 3.3.2.1 Fibronectin secretion by osteogenic-induced MSCs in 2D. Osteogenic-induced 
MSCs were cultured for up to 21 days using 2D culture and fibronectin secretion was examined. 
Fibronectin was produced around condensation of cells during bone nodule formation by 
osteogenic-induced MSCs (A-C). Negative control of MSCs cultured using media without 
osteogenic morphogens showed fibronectin secretion between cells at day 7 and 14 (D-E), with 
indications of mesenchymal condensation being seen by day 21 (F). Scale bar = 200 m.  
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The opposite trend is seen in MSCs cultured without osteogenic morphogens whereby fibronectin 
production is increased with time. At day 7, fibronectin secretion is limited (Figure 3.3.2.2D) and is 
much less than osteogenic-induced MSCs at the same timepoint (Figure 3.3.2.2A). By day 14 and 
21, fibronectin deposition is greatly increased and covers the area of the Scaffold (Figure 3.3.2.2E-
F). The observation from immunofluorescence analysis that non-induced MSCs produce similar 
levels of fibronectin at day 21 (Figure 3.3.2.2F) compared to osteogenic-induced MSCs at day 7 
(Figure 3.3.2.2A) suggest early osteogenesis of non-induced MSCs takes place spontaneously. In 
agreement with previous findings in 2D, the progressive increase in fibronectin secretion implies 
MSCs differentiate spontaneously into an osteogenic lineage without stimulation with osteogenic 
morphogens after 21 days.  
 
3.3.2.3 Fibronectin secretion by MG-63s in 2D and 3D cultures is minimal 
Investigation of fibronectin synthesis by osteoblast-like MG-63s was carried out using 
immunofluorescence. In 3D cultures, little fibronectin production can be seen across the three 
timepoints (Figure 3.3.2.3A-C). The green staining that is present on the images is likely to be non-
specific background staining as some green staining can be detected outside of the Scaffold 
(arrowheads). This indicates the staining that is present is not genuine fibronectin specific binding 
and very little positive staining is present. 2D culture of MG-63 at day 14 showed some indications 
of positive staining of fibronectin between cells (Figure 3.3.2.3D); however this is still quite minimal. 
Fibronectin expression has been suggested to be involved in early osteogenesis, therefore the 
observation that MG-63s do not express/only express a small amount of fibronectin in cultures is 
in agreement with this. MG-63 cells are thought to represent osteoblast-like cells and are 
considered to be mature osteogenic derivatives. This suggests fibronectin expression should be 
limited as MG-63 cells have already differentiated.  
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Figure 3.3.2.2 Fibronectin synthesis by osteogenic-induced MSCs cultured using 3D Scaffold. Osteogenic—induced MSCs displayed positive 
fibronectin staining throughout 3D culture, up to 21 days. Fibronectin production decreased over time (A-C), indicating MSCs differentiating into 
more mature osteogenic derivatives. Negative controls of MSCs cultured without osteogenic factors displayed increasing fibronectin secretion 
from day 7 to day 21 (D-F). Scale bar = 100 m.  
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3.3.3 ECM Deposition – Collagen I 
Collagen I is an essential protein secreted in the bone ECM required for osteogenesis. It is a key 
ECM marker of osteoblast differentiation and comprises 90% of bone ECM. It is vital for matrix 
mineralisation which is the final stage of osteoblast differentiation.  
 
3.3.3.1 Collagen I is secreted in 2D cultures of osteogenic-induced MSCs 
Osteogenic-induced MSCs were maintained for up to 21 days and collagen I secretion was observed 
using immunofluorescence staining (Figure 3.3.3.1). Condensation of cells can be readily detected 
from day 7 (Figure 3.3.3.1A) and collagen I secretion is present at all 3 time points, (Figure 3.3.3.1A-
F) indicating bone nodule formation. Collagen I is deposited in the areas of condensations and not 
outside (data not shown). MSCs cultured with basic media without osteogenic morphogens 
displayed no condensations of cells and mainly negative staining of collagen I (Figure 3.3.3.1G-I). 
However at day 21 (Figure 3.3.3.1I), there are some indications of positive staining in the culture. 
This suggests MSCs may spontaneously begin differentiating into an osteogenic lineage without 
stimulation with osteogenic morphogens after 21 days, which is in agreement with previous 
findings.  
Figure 3.3.2.3 Fibronectin secretion in 2D and 3D cultures of MG-63s. MG-63s displayed little 
positive expression for fibronectin in both 3D (A-C) and 2D (D) cultures. Non-specific background 
staining can be seen outside the Scaffold membrane (arrowheads). Scale bar (A-C) = 100 m, (D) 
= 200 m.  
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3.3.3.2 Collagen I is secreted increasingly over time in 3D cultures of osteogenic-induced MSCs 
Collagen I deposition by osteogenic-induced MSCs in 3D cultures was investigated at day 7, 14 and 
21 (Figure 3.3.3.2). Immunofluorescence analysis displayed clear collagen I secretion (green) into 
the scaffold by the osteogenic-induced MSCs at day 7,14 and 21 (Figure 3.3.3.2A-C). The levels of 
positive staining appear to accumulate with time, suggesting the MSCs are differentiating into more 
mature osteoblasts as there is a greater production of collagen I in the ECM. At day 21, osteogenic-
induced MSCs are able to secrete enough collagen I to cover the Scaffold, leaving collagen I being 
Figure 3.3.3.1 Collagen I is produced by osteogenic-induced MSCs in 2D cultures. 
Representative immunofluorescent images showing osteogenic-induced MSCs secreting 
collagen I up to 21 days during differentiation into osteoblasts (A-F). Clear condensation of cells 
into bone nodules is seen. Collagen I staining without Hoechst (nuclei)  is shown (D-F). Negative 
controls containing MSCs cultured in basic media without osteogenic morphogens did not show 
collagen I secretion up to day 14, with some indications of positive staining at day 21 (G-I). Scale 
bar = 200 m.  
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densely packed in the ECM (Figure 3.3.3.2C). Similar to 2D cultures, the negative controls containing 
MSCs cultured without osteogenic morphogens showed little/no positive staining in day 7 – 14 
(Figure 3.3.3.2D and E) but by day 21 (Figure 3.3.3.2F), there is some collagen I being secreted into 
the ECM. This agrees with the previous finding that by day 21, unstimulated MSCs begin to 
differentiate in an osteogenic lineage without stimulation from osteogenic morphogens. However, 
the amount of collagen I being secreted in the scaffold at day 21 (Figure 3.3.3.2F) is still minimal 
compared to day 7 (Figure 3.3.3A) of osteogenic-induced MSCs.  
 
3.3.3.3 Deposition of collagen I is evident in 2D and 3D cultures of MG-63 cells  
Secretion of collagen I by MG-63s maintained in 2D and 3D cultures was also examined. From 
immunofluorescence analysis, MG-63s appear to produce similar amounts of collagen I across the 
three timepoints in 3D (Figure 3.3.3.3A - C), suggesting production of collagen I reaches a maximum 
saturation point in 3D as MG-63s are already differentiated. MG-63s cultured using 2D methods 
also secreted collagen I at day 14  (Figure 3.3.3.3D). Condensation of cells can also be observed as 
the nuclei (blue) are in close proximity to each other, and collagen I is secreted in this condensation. 
This is similar to results observed with osteogenic-induced MSCs as in both types of cells, collagen 
I secretion is localised to the inside of the condensations.  
 
3.3.3.4 Collagen I expression is greater in 3D cultures than 2D for osteogenic-induced MSCs 
To assess the whether there are differences in collagen I expression between 2D and 3D cultures, 
osteogenic-induced MSCs were maintained in 2D and 3D cultures for up to 21 days. Protein 
lysates of each condition was generated after 7,14 and 21 days and western blotting was used to 
measure the amount of collagen I expressed in each sample. The antibody used for measuring 
collagen I expression cross reacts with different epitopes of collagen I, resulting in numerous 
bands being shown on the blot. Western blot analysis revealed increased expression of collagen I 
for 3D culture at day 7, 14 and 21 compared to their respective 2D culture condition (Figure 
3.3.3.4). The bands are less prominent for 2D cultures and only had one band, suggesting lower 
levels of collagen I expression whereas the 3D cultures produced clearer bands with the 
characteristic numerous collagen I epitope bands. Results suggest osteogenic-induced MSCs 
cultured using Alvetex Scaffold not only increased collagen I expression compared to their 2D 
counterparts, but also expresses more than one epitope of collagen I. As collagen I is a marker for 
MSC differentiation into osteoblasts,  another implication of this is that 3D culture conditions is 
able to support greater differentiation of MSCs into osteoblasts  as collagen I is expressed more 
compared to 2D conditions. The molecular weight of the bands corresponds to mature collagen 
and the antibody recognises epitopes in both alpha-1 and alpha-2 collagens.  
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Figure 3.3.3.2 Collagen I deposition by osteogenic-induced MSCs in 3D cultures increase over time. Representative immunofluorescent analysis 
of increasing collagen I secretion by osteogenic-induced MSCs over time, up to day 21 (A-C). Negative controls containing MSCs cultured in basic 
media omitting osteogenic morphogens show little or no secretion of collagen I (D-F). Scale bar = 100 m.  
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3.3.4 – ECM deposition –  Collagen III  
Collagen III is another major ECM component which is expressed by osteoblasts during 
differentiation. It has been shown to be present in mesenchymal condensations in cultures. 
Expression of collagen III by bone forming cells was also investigated in 2D and 3D cultures.  
Figure 3.3.3.3 Collagen I deposition in 2D and 3D cultures of MG-63s. MG-63 displayed positive 
staining for collagen I for both 2D (D) and 3D (A-C) cultures. MG-63s appeared to produce similar 
levels of collagen I across the timepoints in 3D culture. In 2D culture, at day 14, MG-63 also displays 
positive staining for collagen I. Scale bar (A-C) = 100 m, (D) = 200 m.  
Day 7 2D Day 7 3D Day 14 2D Day 14 3D Day 21 2D Day 21 3D 
Collagen I 
β-actin 
Figure 3.3.3.4 Expression of Collagen I is greater in 3D cultures than 2D counterparts for 
osteogenic-induced MSCs. Representative western blot analysis of collagen I appeared to be 
greater in 3D cultures at each time point compared to 2D cultures. The different epitopes of 
collagen I can be clearly seen for 3D cultures but not 2D. β-actin was used as a loading control.  
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3.3.4.1 Collagen III is expressed in 2D cultures of osteogenic-induced MSCs 
Secretion of collagen III in the ECM by osteogenic-induced MSCs was investigated in 2D cultures. 
Collagen III deposition could be identified by day 7 (Figure 3.3.4.1A and D) as well as 
mesenchymal condensations, indicating bone nodule formation. Collagen III expression is highly 
localised to the inside of the condensations of cells for up to day 21 (Figure 3.3.4.1C and F) which 
is similar to the findings for collagen I expression in 2D cultures by osteogenic-induced MSCs 
discussed previously (Section 3.3.3.1). Negative controls were also included in which MSCs 
cultured with basic media without osteogenic morphogens was stained with the same collagen III 
antibody. Small amounts of positive staining can be seen in all three time points (Figure 3.3.4.1G-
I), and at day 21, there is an indication of cells beginning to aggregate together to form a 
condensation. This agrees with the previous notion suggested whereby by day 21, MSCs may 
naturally begin differentiation towards an osteogenic lineage without induction by osteogenic 
morphogens.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.4.1 – Collagen III is deposited in 2D cultures of osteogenic-induced MSCs. 
Representative immunofluorescence analysis of collagen III deposition (green) and cell nuclei 
(blue). Osteogenic-induced MSCs were cultured up to day 21 (A-F), with collagen III staining only 
shown in (D-F). Negative controls of MSCs cultured using basic media without osteogenic 
morphogens is also shown (G-I). Scale bar = 200 m.  
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3.3.4.2 Collagen III is increasingly deposited in 3D cultures of osteogenic-induced MSCs 
Collagen III production in the ECM of 3D cultures of osteogenic-induced MSCs was also assessed. 
At day 7, minimal amounts of positive staining can be seen, suggesting little collagen III is produced 
in the ECM as cells are only beginning to differentiate (Figure 3.3.4.2A). By day 14 and 21, collagen 
III secretion is more much evident in cultures as cells are differentiating into more mature cells of 
osteogenic lineage (Figure 3.3.4.2B-C). This provides further evidence to suggest MSCs are acquiring 
an osteogenic phenotype and are progressively differentiating into osteoblasts. Collagen I 
deposition (Figure 3.3.3.2) displayed similar results of secretion of collagen III which is expected as 
collagen I and III production are closely linked. Both collagen III and collagen I secretion covers the 
whole area of the Scaffold and is not concentrated in one area. Negative controls containing MSCs 
cultured without osteogenic morphogens show little or no positive staining across all three 
timepoints (Figure 3.3.4.2D-F).  
 
3.3.4.3 Collagen III is secreted at similar levels across 3D cultures and is evident in 2D cultures of 
MG-63 
To examine further the ECM produced by osteoblast-like cells, MG-63 cells were cultured in 2D and 
3D for up to day 21 (Figure 3.3.4.3). Staining for collagen III by immunofluorescence displayed 
similar findings to collagen I (Figure 3.3.3.3). For 3D cultures, collagen III production at day 7,14 and 
21 was comparable between them (Figure 3.3.4.3A-C) as the amount of staining between the 
timepoints remained at similar levels. No significant differences between the samples can be seen 
from the immunofluorescence analysis. Collagen III deposition is also present in 2D cultures of MG-
63s (Figure 3.3.4.3D).  
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Figure 3.3.4.2 – Collagen III is deposited by osteogenic-induced MSCs in 3D cultures. Representative immunofluorescent analysis of collagen III 
secretion by osteogenic-induced MSCs over time, up to day 21 (A-C). Negative controls containing MSCs cultured in basic media omitting 
osteogenic morphogens show little or no secretion of collagen III (D-F). Scale bar = 100 m.  
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3.3.5. ECM deposition – Alkaline Phosphatase (ALP)  
Alkaline phosphatase (ALP) is another important marker in the ECM expressed during early 
osteoblast differentiation, needed to supply phosphate for bone mineralisation – the next stage of 
osteogenesis. The expression of alkaline phosphatase in cultures was measured using a colorimetric 
alkaline phosphatase assay kit as previously described (Section 2.6).  
 
3.3.5.1 Alkaline phosphatase expression is indicative of greater osteoblast differentiation by 
osteogenic-induced MSCs in 3D cultures  
To investigate osteogenesis in 2D and 3D cultures further, the expression of alkaline phosphatase 
was measured in cultures of osteogenic-induced MSCs, up to 21 days. Although no statistical 
significance could be calculated between 2D and 3D at the respective timepoints, the trend of the 
graph still provides useful information (Figure 3.3.5.1). ALP expression in 2D cultures increased over 
time, reaching peak at 21 days whereas in 3D cultures, ALP expression reached its maximum at day 
14 and decreased at day 21. Alkaline phosphatase is expected to increase during osteoblast 
differentiation while decreasing during matrix mineralisation – the stage of osteogenesis which 
Figure 3.3.4.3 – Collagen III deposition in 2D and 3D cultures of MG-63s. MG-63 displayed positive 
staining for collagen III for both 3D (A-C) and 2D (D) cultures. MG-63s appeared to produce similar levels 
of collagen I across the timepoints in 3D culture. In 2D culture, at day 14, MG-63 also displays positive 
staining for collagen III. Scale bar (A-C) = 100 m, (D) = 200 m.  
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following osteoblast differentiation. The trend seen from the ALP assay suggests that in 2D, MSCs 
continue to differentiate into osteoblasts past day 21 and greater matrix mineralisation may take 
place in 3D by day 21 as a decrease in ALP secretion is observed. At day 7 and day 14, osteogenic-
induced MSCs produce greater ALP expression in 3D compared to 2D. This could indicate greater 
osteoblast differentiation in 3D, however this is not statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.6A Matrix mineralisation  
Matrix mineralisation is the last stage of osteogenesis. During this, osteoblasts mineralises the 
extracellular matrix by laying down minerals such as calcium and phosphate. There are several 
markers for matrix mineralisation, one of which is the deposition of calcium which was investigated 
in 2D and 3D cultures of bone forming cells.  
 
3.3.6.1 Detection of calcium deposition in 2D and 3D cultures  
Mineralisation of the extracellular matrix was visualised using Alizarin Red staining in 2D and 3D 
cultures. Osteogenic-induced MSCs were maintained using 2D and 3D cultures, as well as MG-63s 
on 3D cultures. After 21 days, cultures were fixed and stained with Alizarin Red stain following the 
methods described in Section 2.4.1 and 2.4.2. Alizarin Red stains calcium deposits a bright red 
colour, indicative of bone matrix mineralisation. Results are illustrated in Figure 3.3.6.1. At 21 days, 
both 2D and 3D cultures of osteogenic-induced MSCs demonstrate calcification of the matrix due 
Figure 3.3.5.1 Alkaline Phosphatase expression by osteogenic-induced MSCs in 2D vs 3D 
cultures. Although no statistical significance was found between the data, the trend seen on the 
graph is indicative of greater osteoblast differentiation in 3D cultures. At day 7 and 14, 3D culture 
of osteogenic-induced MSCs resulted in greater alkaline phosphatase production compared to 
2D. By day 21, MSCs may have differentiated more to form mature osteoblasts, resulting in 
decreased ALP production compared to 2D. Data represent the mean ± SEM (n= 3).  
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to clear positive red staining (Figure 3.3.6.1A and B). In 2D, multiple mesenchymal condensations 
can be seen and calcium deposition can be detected inside the condensations. However, only 2 of 
the nodules contain an intense red colour, whereas the other condensations are much lighter in 
colour which indicates less calcium being stained (Figure 3.3.6.1A). In 3D cultures, calcium 
deposition can be readily detected by osteogenic-induced MSCs at a much darker red colour (Figure 
3.3.6.1B) compared to 2D culture. This is preliminary evidence to suggest greater calcium 
deposition occurs in 3D compared to 2D, however quantifiable data is needed to support this. MG-
63s cells cultured in 3D also display positive Alizarin Red staining (Figure 3.3.6.1C), with an intense 
red colour which is similar to osteogenic-induced MSCs (Figure 3.3.6.1B).  
 
Previous work which involved culturing osteogenic-induced rat MSCs on Alvetex Scaffold was able 
to display bone nodule formation in 3D cultures using Von Kossa staining. Similar to Alizarin Red, 
the Von Kossa histological stain is used to identify the formation of calcified bone nodules which 
appear as densely dark areas (Figure 3.3.6.1D arrowhead). Using wholemount staining, MSCs 
cultured under osteogenic conditions for 21 days in 3D demonstrated condensation of cells and 
calcium deposition.  
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Figure 3.3.6.1 Histological stains of 2D and 3D cultures of bone forming cells suggests matrix mineralisation. Osteogenic-induced MSCs were cultured in 2D 
(A) and 3D (B) as well as MG-63s (C) for 21 days and stained with Alizarin Red. Alizarin Red stains calcium deposits bright red which is seen in both 2D and 3D 
cultures. Previous work showed Von Kossa staining of osteogenic-induced MSCs in 3D which similarly shows calcium deposition (D, arrowhead). Credit: Hardy, 
S. (2010). Scale bar A and D = 200 m, B and C = 100 m.  
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4. Discussion  
The overall aim of this study was to develop and characterise an in vitro bone tissue model using 
bone forming cells such as primary rat MSCs and cells from the human osteosarcoma cell line MG-
63, to investigate whether 3D cell culture could enhance bone formation. In order to meet this aim, 
several objectives were required to be met. The first was to isolate and characterise primary rat 
MSCs and to identify and culture a bone derived cell line such as MG-63s to provide the bone 
forming cells required for the project. The second objective was to investigate whether 3D scaffolds 
would support the growth and proliferation of bone forming cells. The third objective of the study 
was to compare and analyse the stages of osteoblast differentiation by bone forming cells between 
2D and 3D culture.  
 
By meeting all these objectives, the hypothesis that 3D cell culture techniques would enhance bone 
development by bone forming cells can be investigated by comparing the expression of key 
osteoblast markers between cells cultured by 2D and 3D methods.  
 
4.1 Isolation and culture of bone forming cells  
4.1.1 Isolated cells were confirmed to be true MSCs  
As discussed in Section 1.2, there is a wide variety of representative cell types which are used to 
study osteoblast differentiation and bone tissue formation in vitro. Primary MSCs are a common 
type to use as they have the most physiological relevance in modelling osteoblast differentiation in 
vitro. MSCs from rat bone marrow have been characterised and used commonly to investigate in 
vitro osteoblast differentiation59. Specifically, the bone marrow was chosen as the source of 
isolated cells over adipose tissue as rat BM-MSCs have been shown to proliferate faster and possess 
higher multilineage potential compared to rat adipose MSCs135.  
 
The first stage of the project was to isolate primary rat MSCs as they are much more widely available 
compared to human MSCs. Cells were isolated from rat femurs and tibiae using a commonly used 
methodology134 and MSC-like cells were identified through plastic adherence, morphology, cell 
marker expression and multilineage differentiation potential. Plastic adherence is commonly used 
to characterise isolated MSCs136, which was assessed through the cells’ ability to remain in the 
plastic flasks after extensive passages. Cells displaying fibroblastic-like, spindle shaped morphology 
could be seen using phase contrast microscopy, which has been reported to be the morphology 
MSCs exhibit in vitro137. Analysing the cell-surface marker expression is another method employed 
to isolate MSCs. Flow cytometric analysis revealed the largely positive expression from isolated cells 
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of the mesenchymal marker CD90 (Thy-1), which has been suggested to be involved in early MSC 
differentiation towards osteogenic cells138. The expression of commonly used HSC markers, CD34 
and CD45 were found to be largely negative in isolated cells, confirming the depletion of HSCs from 
culture. However, the use of CD34- being a marker of MSC has attracted controversy, with some 
papers reporting CD34+ MSCs formed greater fibroblastic colonies than CD34- MSCs and CD34 
should be considered a positive marker for MSC139. However, the predominant opinion still accepts 
CD34- as an in vitro MSC marker especially for cells isolated from the bone marrow140, and a large 
number of papers have indicated an absence of CD34 in cultured MSCs29,141,142. CD45 is a HSC 
surface marker, suggested to play a key role in the proliferation and differentiation of 
haematopoietic cells143. The high purity of the MSCs isolated was confirmed as 98.38% of isolated 
cells had expressed CD90, while only 3.05% and 1.22% expressed the haematopoietic markers CD45 
and CD34 respectively (Figure 3.1.2D). This suggests the isolated cells were overwhelming MSCs 
and the continuous passages had removed contaminating haematopoietic cells.   One of the most 
important characteristic of true MSCs is the ability to differentiate into cells of multiple lineages, 
including osteogenic and adipogenic. Using the histological stains Alizarin red and Nile red, MSCs 
were confirmed to be able to differentiate into osteogenic and adipogenic cells respectively. 
 
Since the isolated cells display plastic adherence, fibroblast-like morphology, mesenchymal 
markers cell surface expression and multilineage differentiation ability, the cells comply with the 
minimum criteria set by the International Society for Cellular Therapy (Section 1.2.1.2) for cells to 
be considered as true MSCs. This confirms the isolated cells used in the study are true MSCs.  
 
4.1.2 Selection and culture of a bone derived cell line  
As discussed in Section 1.2.2, primary cells are limited in their availability and their isolation method 
increases the time needed for culture, whereas immortalised cells lines are able to grow for an 
indefinite number of passages. Due to this, a bone derived cell line was also used for preliminary 
tests and to use as a comparison for MSCs to an osteoblast-like cell line (MG-63), which is 
considered to have express some mature osteoblastic features84. MG-63s were successfully 
cultured following the method described in Section 2.2 and used in downstream experiments, along 
with MSCs. Other bone derived cell lines were also considered for use, such as SaOs-2 cell line. As 
previously mentioned, SaOs-2 is similar to MG-63s as it is also derived from human osteosarcoma. 
A study by Pautke et al84 compared the use of osteosarcoma cell lines to human osteoblasts and 
found the SaOs-2 cell line represented the most mature phenotype and displayed similar cytokine 
and growth factor expression to primary normal human osteoblast cells. However, ALP levels in 
SaOs-2 were much higher than primary cells and they do not mirror the whole range of osteoblast 
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phenotypic changes86. Another potential cell line which could have been used in the project is 
MC3T3-E1 which is a common osteoblast cell line used in studies. This cell line was originally derived 
from mouse calvaria cells, however a disadvantage to their use is that they are considered as pre-
osteoblastic87. This would have prevented comparisons made between the primary rat MSCs and a 
more mature phenotype. Overall, due to time and availability of cells MG-63s were chosen as the 
most appropriate cell line to use. A potential future work would be to repeat the study with cells 
from SaOs-2 cell line as this is considered a more mature osteoblast phenotype.  
 
4.2 3D scaffolds supported the growth of bone forming cells  
The project then investigated whether 3D cell culture was able to support the growth of bone 
forming cells. As previously discussed in Section 1.3.2 and 1.3.3., there are various methods of 3D 
techniques which have been shown to support bone growth in vitro. Aggregate formation via 
spheroids is a common technique employed to study bone formation in vitro. However, there are 
issues with this technique such as the limited nutrient diffusion across the centre of the spheroids 
which results in a concentrated hypoxic region of the spheroids, which have been shown to 
upregulate hypoxia-associated genes101. As a result, this project chose to focus on the use of 
scaffolds as cells grown using scaffolds have a much more direct access to nutrients due to the 
porous environment. Another advantage to scaffolds is due to its hard surface which recapitulates 
the bone environments on which osteoblasts attach to. There are various natural and synthetic 
materials which have been used to make the scaffolds. Polystyrene was chosen as the most 
appropriate scaffold material for this project as it is the same material which is used in 2D culture, 
therefore allowing direct comparisons between 2D and 3D – any differences seen with 3D culture 
will most likely be due to the 3D environment and not the material in which the scaffold is made 
of. Alvetex was chosen as the most appropriate 3D cell culture technology to use in the project 
due to its properties such as its polystyrene material and highly porous network resembling the in 
vivo bone matrix, which suggested it would be a suitable scaffold to use for an in vitro bone tissue 
model (Section 1.4.1). Preliminary results with culturing MG-63s on Alvetex scaffold displayed 
homogenous growth throughout the scaffold for up to 28 days, suggesting 3D scaffolds are able to 
support the growth of bone forming cells.  
 
4.2.1 Porosity of scaffolds affect the distribution and proliferation of bone forming cells  
The pore sizes and porosity of 3D scaffolds has been reported to be significant in the regulation of 
the morphology and behaviour of cells of osteogenic lineage144. Porosity is vital for modelling bone 
formation as it allows cellular infiltration, proliferation and matrix deposition145. Alvetex also 
contains high interconnectivity between the pores, which is a property of scaffolds which has been 
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shown to promote osteogenic tissue growth105,146. Since Alvetex is available in three formats which 
have varying void sizes and interconnected distributions, bone forming cells were cultured using all 
three formats to determine the effect of porosity on the proliferation. Scaffold was chosen as the 
most appropriate format as it produced the greatest proliferation and homogenous growth for both 
MSCs and MG-63s. This is due to the larger pore size being closer to the mean pore size of 96 - 
150m which has been suggested to facilitate optimal attachment for bone tissue engineering147. 
The larger pore size also allows the cells to migrate in towards the scaffold148, allowing for 
homogenous growth throughout the scaffold and not only on the top of the membrane like with 
Polaris. Since Strata has a smaller void size than Scaffold and cells were still able to proliferate and 
grow on the Strata membrane, this suggests cells on Scaffold were actively migrating in and not just 
falling through. Similarly, osteogenic-induced MSCs also showed better proliferation and coverage 
when cultured on Scaffold rather than Strata as well as secretion of ECM.  
 
Alvetex Scaffold was designed for the dissociation of mammalian cells within the scaffold, while 
Strata and Polaris allows for cell growth on the surface of the membrane in order to form layers 
either on the top or bottom of the membrane (ReproCELL Europe Ltd). Due to the hypothesis of 
the project being that a more similar microenvironment to the in vivo bone niche of the 3D cell 
culture technology will enhance bone formation, Scaffold was also chosen as cells are able to 
penetrate the membrane and dissociate in a way which is similar to the normal behaviour of bone 
forming cells in the bone marrow. Previous work with osteogenesis on Alvetex also chose to use 
Scaffold132,133, suggesting that it is the best format to use and allowing for cross-study comparisons.   
 
4.3 Osteogenic differentiation in 2D vs 3D  
4.3.1 3D cell culture supports the proliferation stage of osteogenesis 
Proliferation is the first stage of osteogenesis, whereby bone forming cells replicate and undergo 
cell division to increase the number of cells in culture (Section 1.2.1.4). For the study, comparing 
the proliferation rates accurately between 2D and 3D was faced with difficulty. This is due to the 
large difference in seeding number between 2D and 3D (3 x 103 cells/cm2, 2 x 104 cells/cm2 and 5 x 
105 cells) (MSC and MG-63, 2D and 3D respectively). This made it difficult to draw accurate 
comparisons between the proliferation rates from images alone as the 2D images were not 
representative -  they could not capture the entire culture of the cells. In general, bone forming 
cells cultured on 2D was seen to proliferate during the earlier stages of culture and reduced during 
later stages (data not shown).  
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However, for 3D, proliferation of cells could be indicated by assessing the nuclei distribution from 
H&E images and nuclei counts. As osteogenesis is a gradual and progressive process, three time 
points were used to represent the early, middle and end stages of osteoblast differentiation (Day 
7, 14 and 21). From the results shown in Figure 3.3.1 and Figure 3.3.1.1, osteogenic-induced MSCs 
and MG-63s were suggested to reach peak proliferation levels by day 7 and remained at similar 
levels up to day 21. As discussed in Section 1.2.1.4, proliferation by osteogenic cells are required to 
increase during the early stages of osteogenic differentiation but is needed to decline/remain at 
similar levels in order to proceed to the next stage55. These results suggest Alvetex scaffold is able 
to support the proliferation stage of osteogenesis in both 2D and 3D; however, more information 
and analysis is required to compare the proliferation rates between 2D and 3D. A more quantitative 
approach could have been used to measure the proliferation rates between 2D and 3D, to further 
improve the accuracy of results. One such method which could be used is the PicoGreen assay, 
which is a fluorescent probe which binds to dsDNA for use in DNA quantitation149. This quantitation 
assay is easy to use as you add the dye to the sample, incubate for 5 minutes and read using a 
microplate reader, therefore it is viable option for quantifying the proliferation rates in 2D and 3D 
as the greater the proliferation, the greater the reading will be from the assay.   
 
4.3.2. ECM maturation and deposition by bone forming cells in 2D vs 3D 
Following proliferation, the next stage of osteogenesis by bone forming cells is the maturation and 
deposition of bone ECM. To assess the levels of ECM deposition by bone forming cells, numerous 
osteoblast markers which are important in this stage can be detected and identified. The 4 markers 
used in this project are: fibronectin, collagen I, collagen III and alkaline phosphatase, which have 
been commonly used in studies to assess osteoblast differentiation108,119.  As previously discussed 
in Section 1.2.1.4, there are many markers which are commonly used to assess levels of maturation 
of osteogenic differentiation in vitro. Fibronectin is an important glycoprotein found in the bone 
ECM which is shown to have a role in osteoblast recruitment61. Collagen is the major structural 
component of the organic bone matrix, therefore a highly important marker of osteoblast 
maturation and bone matrix formation. Collagen I and collagen III were used as a markers of 
osteoblast maturation as it is vital for matrix mineralisation and those are the types of collagen 
which are the most abundant in natural bone 150. Alkaline phosphatase is one of the most commonly 
used markers of osteoblast maturation as it needed for the production of hydroxyapatite and 
consequently the mineralisation of bone matrix (Section 1.2.1.3). ALP was used as a marker in this 
project as it has been shown to have a critical role in bone formation151, thereby ALP expression by 
cells is highly indicative of osteoblast maturation and bone nodule formation.   
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4.3.2.1 Fibronectin secretion can be detected in 2D and 3D cultures of bone forming cells 
As mentioned previously, fibronectin is a key marker of osteogenesis which is thought to be 
involved during the early stages of osteogenesis. In 2D cultures of osteogenic-induced MSCs, 
fibronectin secretion was localised to areas around the mesenchymal condensations and not inside 
(Figure 3.3.2.1), as seen with the positive green staining. This is in agreement with the roles of 
fibronectin that have been suggested by the literature, as several papers have reported that 
fibronectin is deposited in areas of recruitment and commitment of osteoblast precursors. This is 
due to their function in regulating the adhesion, migration and maturation of osteoblasts61. In 2D, 
with time, the condensations of cells increase and fibronectin was only detected around the 
borders of the bone nodules. This allows fibronectin to communicate to and recruit precursors 
outside of the nodules to migrate in and expand the condensations.  
 
In 3D, fibronectin secretion was seen to decrease with time which complies with findings in the 
literature where the expression of fibronectin mRNA reduced with time152. In this paper, fibronectin 
was reported to increase during proliferation and early differentiation, and decline as cells mature. 
This indicates that after day 7 in 3D, osteogenic-induced MSCs are differentiating into more mature 
osteoblast derivatives as their fibronectin secretion sharply reduces at day 14 and even more so at 
day 21 (Figure 3.3.2.2). The finding that fibronectin deposition decreases with maturing osteoblast 
differentiation is supported by the lack of detection of fibronectin secretion by MG-63 cells in both 
2D and 3D. MG-63 are considered to be more mature osteoblast-like cells, therefore it is expected 
that fibronectin expression to be limited as they are no longer at the early stages of osteogenesis. 
Comparing fibronectin secretion between 2D and 3D using immunofluorescence alone is not 
accurate as the images do not provide a representation of all the cells in each culture. In order to 
compare 2D and 3D fibronectin secretion, quantitative data is needed such as measuring mRNA 
expression. Since there are some indications of little positive staining in 2D culture of MG-63 and 
none in 3D cultures, this suggests 3D culture of MG-63 could allow cells to differentiate further into 
more mature osteoblasts. However, more data analysis to fully support this.  
 
4.3.2.2 Collagen I and III secretion can be detected in 2D and 3D, with increased Collagen I in 3D 
Collagen I and III are important proteins in bone ECM, with 90% of the organic bone matrix being 
made up of collagen I5. Additionally, cells must be in connection with a collagen I-containing matrix 
in order to differentiate45,59 – osteogenic-induced MSCs and MG-63s were seen to secrete collagen 
I and III in both 2D and 3D. This further indicates that cells are differentiating towards more mature 
osteoblast derivatives in both 2D and 3D cell culture. For osteogenic-induced MSCs in 2D, collagen 
I and III secretion could be detected in the condensations of osteogenic-induced cells which are 
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indicative of bone nodule formation52. In 3D, an increase in collagen I and III secretion over time 
could be seen in osteogenic-induced MSCs which suggests the 3D scaffold is able to support ECM 
deposition and matrix maturation as collagen I and III could accumulate over time. To compare 
collagen I expression between 2D and 3D, a western blot analysis was carried out for osteogenic-
induced MSCs (Figure 3.3.3.4). The results suggest in 3D, osteogenic-induced MSCs produce more 
collagen I as the bands are more prominent and included numerous epitope bands compared to 
2D. This indicates that culturing osteogenic-induced MSCs on a 3D scaffold is able to produce more 
collagen I and is able to differentiate into more mature osteoblast derivatives, a finding which has 
been reported in literature using different types of 3D scaffolds108,153. For MG-63s on 3D, no 
significant differences could be seen for collagen I and III points between day 7, 14 and 21. This 
suggests that as MG-63 cells have already differentiated by the time they are seeded on the 
Scaffold, the cells secrete a consistent level of collagen I and III across the increasing timepoints. 
 
4.3.2.3 Alkaline phosphatase activity is indicated to be greater in 3D cultures  
ALP is a very important enzyme in the bone matrix which is widely used as a marker of osteoblast 
differentiation. From the results presented in Figure 3.3.5.1, osteogenic-induced MSCs produced a 
higher expression of ALP in 3D compared to 2D at day 7 and 14, while decreasing at day 21. 
Although the results were not statistically significant, the trend presented is still indicative of 
osteogenesis by the osteogenic-induced MSCs. According to the sequence of osteoblast marker 
expression which was first defined by Lian and Stein91, ALP activity reaches a maximum peak at 14 
days during osteoblast differentiation and subsequently decreases during matrix mineralisation at 
day 21, a finding which has also been widely reported in literature (Section 1.2.1.4). The decrease 
at day 21 is associated with the acquisition of a more mature osteoblastic phenotype. This trend 
was seen in osteogenic-induced MSCs in 3D, whereas MSCs in 2D continue to increase ALP 
expression past day 14. This indicates that the osteogenic-induced MSCs cultured on Scaffold has 
reached maximum matrix maturation by day 14 and undergoes the matrix mineralisation stage by 
day 21. In contrast, the increasing trend of ALP activity seen in 2D suggests osteogenic-induced 
MSCs may not have matured as greatly as 3D at day 21 and matrix maturation is reduced. The ALP 
expression is also greater for 3D than 2D at day 14, suggesting 3D does enhance bone formation.  
However since this is not statistically significant, more repeats will need to be conducted to reduce 
the error bars and increase significance.  
 
ALP activity has been reported to increase in osteogenic-induced MSCs cultured on Alvetex 
Scaffold. Ruminski et al cultured human adipose-derived mesenchymal stem cells (ADSCs) using the 
routine 2D environment and 3D culture (Alvetex Scaffold) and induced the cells with osteogenic 
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differentiation medium. They reported an elevated ALP activity at their longest time point (day 7) 
for cells cultured on Scaffold compared to 2D154, which is similar to the results presented in this 
study. Similarly, an increase ALP activity and mineral deposition was seen in ADSCs cultured on 3D 
scaffolds (made of reduced graphene oxide/polydimethylsiloxane)155.     
 
Previous work carried out at Durham University involved culturing osteogenic-induced rat MSCs on 
Alvetex Scaffold which reported a statistically significant enhancement of ALP activity on cells 
cultured on 3D compared to 2D at day 5, 7, 14 and 21. Since this study used the same method of 
cell culture, osteogenic differentiation and same type of cells, this suggests the lack of statistically 
significant results in Figure 3.3.5.1 could be due to human error and requires more than 3 repeats 
to improve the size of the error bars. This study showed that MSCs cultured on Scaffold display an 
enhanced osteoblastic functional behaviour156. Likewise, culturing MG-63s on Scaffold resulted in 
significantly greater levels of ALP compared to 2D plastic surfaces, further indicating Alvetex 
Scaffold is able to enhance osteoblast maturation of bone forming cells133.  
 
4.3.3 Matrix mineralisation can be seen in both 2D and 3D cultures 
Matrix mineralisation is considered to be the last stage of osteogenesis, whereby osteoblasts 
deposit minerals such as calcium and phosphate into the organic matrix. As discussed previously in 
Section 1.2.1.4, the commonly used methods to assess matrix mineralisation in in vitro cultures is 
through histological stains such as Von Kossa and Alizarin Red. Alizarin Red was used to stain both 
2D and 3D cultures of bone forming cells at day 21, which binds to calcium deposits and stains an 
intense red colour66. In 2D of osteogenic-induced MSCs, bone nodules can be readily seen with 
some containing an intense red colour, while others are express lighter shades of red. In 
comparison, osteogenic induced MSCS and MG-63s on 3D produce a much darker red colour, which 
is indicative of greater calcium deposition by the cells (Figure 3.3.6.1A-C). As MG-63s are considered 
to be osteoblast-like, this indicates that by day 21, osteogenic-induced MSCs have differentiated 
into mature osteoblasts in 3D similar to MG-63. However, these findings are only preliminary and 
requires other data to support this such as through quantifying the amount of Alizarin Red staining.  
 
Previous work at Durham university demonstrated positive Von Kossa staining on wholemount 3D 
cultures of rat osteogenic-induced MSCs156. Figure 3.3.6.1D displays clear condensation of cells 
cultured on Alvetex Scaffold, which was stained an intense black colour which is indicative of 
calcium production. This further supports the finding that MSCs cultured in 3D are able to complete 
all stages of osteogenesis, with calcium deposition being a marker of matrix mineralisation which 
is the final stage. This preliminary result suggests culturing osteogenic-induced MSCs in 3D could 
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produce greater calcium deposition. However, in order to compare levels of matrix mineralisation 
between 2D and 3D, other methods such as quantifying histological stains is required to make 
accurate comparisons. One common method that is used to quantify histological stains is through 
eluting the stain and reading the amount present using a spectrophotometer157. This results in a 
standard curve and the amount of calcium deposition can be expressed as equivalent to the amount 
of calcium bound to Alizarin Red/Von Kossa.   
 
4.3.4 Spontaneous osteogenic differentiation by rat MSCs in vitro 
Another key finding of the study which has been supported throughout is the spontaneous 
osteogenic differentiation by rat MSCs. In 2D immunofluorescence images of fibronectin, collagen 
I and collagen III, condensations of MSCs cultured using media without osteogenic morphogens can 
be seen by day 21 (Figures 3.3.2.1F, 3.3.3.1I, 3.3.4.1I), which is indicative of bone nodule formation. 
Similar findings have been reported in literature as a behaviour of rat MSCs. Karaoz et al described 
the expression of bone morphogenic proteins (BMP2 and BMP4) by rat bone marrow MSCs without 
stimulation by osteogenic morphogens which are considered to be key osteogenesis markers158. 
Huang et al demonstrated spontaneous cellular aggregation and calcification in rat bone marrow 
MSCs cultured using media without osteogenic morphogens by day 21 by phase contrast 
microscopy and positive Alizarin Red staining159. This behaviour was not observed in goat or human 
bone marrow MSCs cultured using the same system160. These results support the finding that rat 
bone marrow MSCs possess a tendency of spontaneous calcification in vitro and differentiate into 
an osteogenic lineage spontaneously.  
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4.4 Conclusions  
This study investigated the use of a 3D scaffold to culture bone forming cells in order to develop an 
in vitro bone tissue model, with an aim to model the stages of osteoblast differentiation and bone 
tissue formation. The findings of the study demonstrated successful isolation of primary rat MSCs 
and culture of a human osteosarcoma cell line (MG-63) to provide the bone forming cells required 
for the study. The 3D scaffold was able to support the proliferation of both primary rat MSCs and 
MG-63 cells, suggesting it would be an appropriate material to use to develop a bone tissue model. 
Successful osteogenic differentiation in both 2D and 3D was demonstrated though the use of 
different methods such as histological stains and immunofluorescence. Porosity of the Scaffold was 
seen to affect the proliferation and distribution of bone forming cells. Overall, using the results of 
the study and previous work at Durham University,  comparisons of osteogenic differentiation in 
2D and 3D by bone forming cells showed indications of increased collagen I and alkaline 
phosphatase secretion and greater matrix mineralisation in 3D. However, other techniques such as 
qualitative methods should be used to further improve the accuracy of comparisons made between 
2D and 3D.  
 
Collectively, the use of Alvetex Scaffold to culture bone forming cells reported indications of 
enhanced bone formation compared to 2D methods. This highlights the relevance of using 3D cell 
culture systems to model bone tissue development in vitro.  
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4.5 Future Directions  
The data presented in this study provides a foundation for studying bone tissue development in 
vitro using a 3D cell culture system. Due to the time constraints of the project, there are additional 
investigations that can be conducted in order to support the findings and further enhance bone 
formation in 3D.  
 
As mentioned previously, further comparisons are needed to measure the differences in levels of 
osteogenesis between 2D and 3D. Although, histological stains, immunofluorescence, Western blot 
and ALP assays were techniques used to measure osteogenesis in 2D and 3D, the data provided is 
largely qualitative which makes it difficult to see small differences between 2D and 3D and results 
could be interpreted differently. One common quantitative method used is using specific bone 
marker enzyme-linked Immunosorbent Assay (ELISA) systems. Sandwich ELISA Kits are highly 
specific for secreted markers and widely used as quantitative assessments of bone formation. One 
such ELISA kit which is commonly used is for osteocalcin161, which would be another useful marker 
to use to compare osteogenesis between 2D and 3D. Another quantitative method which could be 
used is real-time quantitative polymerase chain reaction (RT-qPCR)162 which measures the mRNA 
levels of bone markers to quantify the difference in bone marker expression between 2D and 3D.  
 
Since the majority of bone markers used in this study are largely involved in the early stages of 
osteogenesis, a beneficial further investigation for the study is to use markers associated with later 
stages. One such marker is osteocalcin, which is considered to be a bone-specific marker indicative 
of mature osteoblast differentiation as it is involved in matrix mineralisation163. Other bone markers 
which could be measured in 2D and 3D osteogenesis are: runx278, BMP-2164, BSP8 and 
osteopointin165 which are all commonly used as osteoblast differentiation markers. If higher levels 
of these markers are found in 3D, this will further support the finding that 3D cell culture is able to 
enhance bone nodule formation.  
 
There have been suggestions of interactions between fibronectin and collagen as fibronectin 
binding to collagen I and III has been reported in vitro. Fibronectin has been shown to be required 
for collagen organisation and deposition166. Another potential further work for the project is to 
investigate the interactions between collagen and fibronectin in osteoblast differentiation by rat 
MSCs and MG-63s and test whether these interactions are enhanced in 3D.   
 
Several conditions have been shown to enhance bone formation in vitro which could be further 
investigated in this study. One example of this is to induce hypoxic conditions during osteogenic 
 78 
 
differentiation of MSCs, which has been shown to enhance proliferation and promote osteogenic 
differentiation in human mesenchymal stromal cells. Osteoblasts have been shown to operate 
under low oxygen (hypoxic) microenvironments in vivo and express hypoxia-inducible factors (HIF1) 
and HIF2, whereby HIF1 is thought to be a positive regulator for bone formation167.  By 
recapitulating these hypoxic conditions in the in vitro bone tissue model, bone formation may be 
enhanced even further in 3D as the osteoblast microenvironment will be more of an accurate 
representation of in vivo conditions.    
 
Another potential further investigation which could be carried out to enhance bone formation 
further in 3D is through coating the Alvetex Scaffold with osteoinductive materials such as collagen 
and hydroxyapatite. Collagen-based scaffolds have been shown to increase bone formation and are 
widely used in bone tissue engineering. Culturing rat MSCs on a collagen coated porous scaffold 
resulted in enhanced ALP activity and cell number, as well as upregulation in gene expression of 
osteocalcin and collagen I thereby increasing osteoblast differentiation168. A study by Lee et al 
investigated the effects on osteoblast differentiation by MG-63 by the addition of hydroxyapatites 
onto porous scaffolds, including Alvetex Scaffold. The study reported enhancement and early 
onset of mineralisation and osteoblastic cell proliferation when hydroxyapatite was incorporated 
into the Scaffold169. This could be a potential further work for the project.  
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